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Abstract 
Nausea and vomiting are commonly experienced by women in pregnancy (NVP). 
Symptoms are usually limited to the first trimester, but can persist until birth. Both mild 
and more severe symptoms can have negative effects for the mother, her unborn child, 
and the family. Despite the frequency of NVP and associated distress, the exact cause 
is unknown and the condition remains poorly understood. 
 This secondary analysis explores nausea and vomiting in pregnancy, as 
determined by the Nausea and Vomiting in Pregnancy Instrument (NVPI), in a cohort of 
Canadian pregnant women at two gestational time points. The data analyzed in this 
study were originally from a longitudinal and epidemiological study of depression in 
pregnancy and into the postpartum. A population health approach has been used to 
examine psychosocial determinants of nausea and vomiting in pregnancy.  
 During the second trimester, the prevalence of nausea and vomiting in this 
sample of 551 women was 63.3%, with 24% of women reporting moderate nausea and 
vomiting and 18.9% reporting severe symptoms. These rates are similar to other studies 
of women during the first and second trimester of pregnancy. In the final model, nausea 
and vomiting in pregnancy was associated with gestation (weeks), antiemetic 
medication use, employment status, worry, and symptoms of major depression. 
During the third trimester, the prevalence of NVP in this sample of 575 women 
was 45.4%, with 8.2% reporting moderate nausea and vomiting and 14.3% reporting 
severe symptoms. These results exceed previous reports on prevalence beyond 20 
weeks in pregnancy. In the final model, nausea and vomiting in pregnancy was 
associated with antiemetic medication use, worry, and symptoms of major depression. 
The presence of support and maternal smoking were found to have a protective effect. 
 The co-morbidity of nausea and vomiting, worry, and symptoms of major 
depression in this sample of pregnant women represents a significant public and mental 
health problem. Care providers need to screen pregnant women for nausea and 
vomiting and also screen women for depression in the presence of more severe NVP 
symptoms. Supportive measures that address both conditions may be necessary in 
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order to improve the quality of life of pregnant women, their families, and to protect the 
unborn child from the effects of both nausea and vomiting and depression in pregnancy.  
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Chapter 1 
Introduction 
Nausea and vomiting is a common experience for women in pregnancy (NVP). 
Symptoms are usually limited to the first trimester, but can continue throughout pregnancy 
and even persist until the birth (OʼBrien & Zhou, 1995). The severity of nausea and vomiting 
may affect the physical and emotional health of the pregnant women (Deuchar, 1995), 
family, social and occupational functioning (Chou, Chen, Ku, & Tseng, 2006; Locock, 
Alexander, & Rozmovits, 2008), the stages of maternal role attainment (Meighan & Wood, 
2005), and even outcomes for the unborn child (e.g., low birth weight) (Zhou, OʼBrien, & 
Relyea, 1999). The cause is unknown, but it is widely agreed that NVP is a multifaceted 
condition with genetic, physiological, behavioural, social, and psychological contributing 
determinants. However, the reports regarding these determinants continue to be 
contradictory and are often restricted to either the first trimester of pregnancy or hyperemeis 
gravidarum (HG), the most severe form of NVP (Broussard & Richter, 1998). 
The extent of the distress associated with nausea and vomiting on the daily lives of 
women is substantial. Women with NVP report concerns about economics and employment 
(Poursharif et al., 2008), have high levels of stress (OʼBrien & Zhou) and worry that the 
symptoms could adversely affect their baby (Mazzootta, Stewart, Atanackovic, Koren, & 
Magee, 2000). Women suffering severe and prolonged nausea and vomiting in pregnancy 
have reported depressive and anxious feelings (Poursharif et al., 2008), changed plans for 
future children, considered termination of otherwise wanted pregnancies (Mazzotta et al., 
2000; Mazotta, Magee, & Koren, 1997), and have reported characteristics of Posttraumatic 
Stress Disorder (PTSD) after the birth of their baby (Fejzo et al., 2009). Pregnant women 
who are depressed or who did not intend to become pregnant are both more likely to use 
cigarettes, alcohol, and drugs during pregnancy and are less likely to have adequate 
prenatal care (Hellerstedt et al., 1998; Naimi, Lipscomb, Brewer, & Gilbert, 2003; 
Zuckerman, Amaro, Bauchner, & Cabral, 1989). The literature has shown that worry, stress, 
anxiety (Austin, Leader, & Reilly 2005; OʼKeane & Scott, 2005; Teixeira, 1999), depression 
(Chung, Lau, Yip, Chiu, & Lee, 2001), and unintended pregnancy (Brown, & Eisenberg, 
1995) as well as cigarette (U.S. Department of Health and Human Services, 1990), alcohol 
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and drug use (Allen & Feeney, 1997) can all have deleterious effects on the health of the 
fetus, the baby, and the mother. The full extent and implications of NVP warrant early 
intervention, which is thought to decrease the severity and duration of the condition as well 
as prevent complications. However, due to the nonlife-threatening nature and commonality 
of the condition, both care providers and pregnant women often tend to minimize the impact 
of NVP (Attard et al., 2002; OʼBrien & Naber, 1992), thus the condition is often inadequately 
treated. 
It is anticipated that this research will add to the growing body of knowledge about 
nausea and vomiting in pregnancy. Increased understanding about the prevalence and 
determinants associated with nausea and vomiting at multiple time points will inform care 
givers and researchers about the factors affecting the well-being of the mother, the family, 
and the unborn child throughout pregnancy. Screening and early intervention of nausea and 
vomiting may help to prevent more severe symptoms in later pregnancy. In addition, early 
intervention of secondary conditions such as anxiety and depression may help to prevent 
their negative effects and associated obstetrical complications for the mother and her baby. 
Finally, it is hoped that the findings will increase awareness of pregnant women suffering 
from nausea and vomiting, a very common condition in pregnancy.  
1.1 Purpose 
The purpose of this project is to increase our understanding of nausea and vomiting 
in pregnancy in a group of mostly urban Canadian women. It will determine the prevalence, 
as well as the sociodemographic, obstetrical/biological, psychological, and behavioural 
determinants of moderate and more severe nausea and vomiting symptoms. Determining 
the prevalence and determinants of NVP can help us to target women at increased risk for 
screening and treatment. There is increased opportunity in pregnancy to anticipate those 
women at risk for nausea and vomiting and consequently to improve the quality of life for the 
mother, her baby, and her family. 
1.2 Research Questions and Hypotheses 
This study will investigate the following four research questions and respective 
hypotheses. These questions begin with an estimation of prevalence rates and then 
progress to more specific questions to identify the determinants of nausea and vomiting in 
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this sample. The symptom profile of nausea and vomiting in the total sample of women will 
be explored and compared among women with different degrees of symptoms: those with 
mild or less than mild symptoms, moderate symptoms, and more severe symptoms.  
1.2.1 Question 1. What is the prevalence of nausea, retching, and vomiting at two 
gestational time points in this sample of pregnant women and is this prevalence different 
from rates reported in the literature? 
The prevalence of nausea, retching, and vomiting prior to 20 weeks in pregnancy will 
be comparable to prevalence reported in the literature for women in the first and second 
trimester of pregnancy (50% to 90%). The prevalence of nausea, retching, and vomiting 
beyond 20 weeks in pregnancy will also be comparable to the prevalence reported in the 
literature for these women (10-32%).  
Hypothesis. Pregnant women taking medication to relieve nausea at Time 1 will 
report less severe nausea and vomiting in pregnancy. Similarly, pregnant women taking 
medication to relieve nausea at Time 2 will report less severe nausea and vomiting in 
pregnancy. 
1.2.2 Question 2. What sociodemographic, biological/obstetrical, psychological, and 
behavioral determinants are associated with moderate and severe nausea and vomiting at 
Time 1 in this group of pregnant women? 
Hypothesis. Pregnant women at Time 1 with more severe nausea, retching, and 
vomiting symptoms will be of younger age, lower level of education, lower level of income or 
not working, have fewer pregnancies, have fewer supports, have more worry, more 
stressors, more mood swings, more psychological problems, and are not engaged in risk 
behaviours compared to women with mild or less than mild nausea and vomiting symptoms. 
1.2.3 Question 3. What sociodemographic, biological/obstetrical, psychological, and 
behavioral determinants are associated with moderate and severe nausea, retching, and 
vomiting at Time 2 in this group of pregnant women? 
Hypothesis. Pregnant women at Time 2 with more severe nausea, retching, and 
vomiting symptoms will be of younger age, lower level of education, lower level of income or 
not working, have fewer pregnancies, have fewer supports, have more worry, more 
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stressors, more mood swings, more psychological problems, and are not engaged in risk 
behaviours compared to women with mild or less than mild nausea and vomiting symptoms. 
1.2.4 Question 4. What is the nature of the relationship between nausea and 
vomiting and psychological determinants, as well as antiemetic and psychotropic 
medications, as evidenced by two time points in pregnancy? 
Hypothesis. Pregnant women with more severe nausea and vomiting symptoms will 
have more psychological symptoms in pregnancy and women taking mediation to relieve 
nausea will have less psychological symptoms in pregnancy. In addition, women who report 
severe nausea and vomiting and symptoms of major depression at Time 1, as well as no 
symptoms of major depression at Time 2, will be associated with less severe NVP at Time 
2. 
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Chapter 2 
Literature Review 
 Chapter two describes the epidemiology and the effects of nausea and vomiting 
during pregnancy on the woman, the fetus, and the family. The sociodemographic, 
obstetric/biological, psychological, and behavioural determinants of NVP as well as the 
etiology of the condition are discussed. The chapter ends with an examination of 
preventative measures and treatment guidelines for women whose pregnancy experience is 
dominated and often diminished by nausea and vomiting. 
2.1 Epidemiology of Nausea and Vomiting in Pregnancy  
Since the time of Hippocrates, nausea and vomiting in pregnancy (NVP) has been 
recognized as a sign of early pregnancy. Nausea is a subjective and disagreeable feeling 
experienced in the back of the throat, which usually results in vomiting (Grant, 1987; Lang, 
1990). Vomiting is the reflex causing the forceful expulsion of the contents of the stomach or 
intestine or both (Davis, Lake-Bakaar, & Grahame-Smith, 1986). Retching or dry heaving 
without vomiting has also been recognized as a distinct symptom of the condition that is 
increasingly measured separately (Lacasse, Rey, Ferreira, Morin, & Berard, 2008; OʼBrien, 
Relyea, & Taerum, 1996; Zhou, OʼBrien, & Soeken, 2001).  
In contemporary Western populations, the prevalence of nausea and vomiting in 
early pregnancy ranges from 50% to 90% and may include mild to severe nausea and 
retching, with or without vomiting (Broussard & Richter, 1998; Miller, 2002; Woolhouse, 
2006). Hyperemesis gravidarum (HG) is the most extreme manifestation of the condition 
(Hod, Orvieto, Kaplan, Friedman, & Ovadia, 1994) and occurs in approximately 0.5%-2% of 
pregnancies (American College of Obstetrics and Gynecology, 2004). HG is characterized 
by persistent nausea resulting in vomiting severe enough to interfere with nutrition and fluid 
intake, and may require close medical monitoring. Whether NVP and HG are independent 
conditions or a part of a continuum of illness remain unclear. 
The lay term ʻmorning sicknessʼ is based on the assumption that symptoms 
commonly occur in the morning. However, only 17% of those with nausea experience it 
solely in the morning; for others, it can occur at any time and last all day (Whitehead, 
Andrews, & Chamberlain, 1992). The onset of symptoms is typically between four to eight 
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weeks after conception, and begins to decline around the twelfth week, with symptoms 
disappearing by week 20 for most women (Gadsby, Barnie-Adshead, & Jagger, 1993; 
Klebanoff, Koslowe, & Kaslow, 1985; Lacroix, Eason, & Melzack, 2000; Whitehead et al., 
1992). A prospective study in 160 American women that examined patterns of symptoms 
daily throughout pregnancy found that 90% of women experienced the onset of symptoms 
by week 8 of gestation, and 90% experienced relief of symptoms by week 22 (Lacroix et al., 
2000). More recently, it has been reported that symptoms of NVP can persist into late 
pregnancy for up to 32% of women (Lindseth & Vari, 2005). 
2.2 Etiology 
The cause remains unknown, thus NVP is a diagnosis of exclusion. Fever, abdominal 
pain (unless caused by retching) and diarrhea are not associated with NVP (Davis, 2004). 
Other pathological causes of nausea and vomiting must be considered and excluded before 
concluding that the symptoms are triggered from pregnancy. These include peptic ulcers, 
cholecystitis, gastroenteritis, appendicitis, hepatitis, thyroid disease, adrenocortical 
insufficiency, genitourinary disorders such as pyelonephritis, metabolic and neurological 
disorders (Koch, 2002; Quinlan, 2003).  
Changing maternal circulatory levels of reproductive hormones early in pregnancy 
have been implicated as potential mechanisms triggering nausea and vomiting. The 
endocrine factor most commonly implicated is human chorionic gonadotropin (hCG) and is 
based on two arguments. First, the pattern of hCG secretion in early pregnancy tends to 
parallel the onset, peak and decline of NVP symptoms. Second, conditions with higher 
levels of hCG, such as multiple pregnancies and molar pregnancies, have been associated 
with a higher risk of nausea and vomiting (Goodwin, 2002). Hormonal studies of women 
with and without NVP indicate that higher levels of hCG are more often associated with NVP 
symptoms. Of the 17 studies published since 1977, 13 reported a positive association 
between hCG and NVP compared to women without NVP (Goodwin). It has been suggested 
that the lack of consistency of some studies to show a relationship may be explained by the 
complex interactions between different forms of hCG and biologic activity (Goodwin, 2000).  
Estrogen has also been held responsible in producing NVP as indirect evidence 
points to an increased likelihood of NVP in women with higher estrogen levels (Goodwin, 
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2002). Variations in postoperative nausea and vomiting by menstrual cycle (Beatie, Buckley, 
& Forrest, 1991) and the dose related nausea and vomiting related to birth control pills 
suggest that estrogen is involved (Jarnefelt-Samsioe et al., 1985; OʼBrien & Zhou, 1995). 
However, relatively few studies have explicitly examined estrogen concentrations in women 
with and without NVP, and they have not found consistent associations. Two studies of NVP 
and estrogen reported higher levels of estrogen in symptomatic women (Jarnfelt-Samsioe, 
Bremme, & Eneroth, 1986; Lagiou et al., 2003) and one study reported no association 
(Masson, Anthony, & Chau, 1985). Three studies reported positive associations between 
hyperemesis gravidarum and estrogen (Depue, Bernstein, Ross, Judd, & Henderson, 1987; 
Goodwin, Montoro, Mestman, Pekary, & Hershman, 1992; Youneyama et al., 2002) and one 
found no association (Jordan et al., 1999). There is considerable variation across studies in 
the timing of data collection, ranging between 4 and 38 weeks. This is problematic as 
hormonal levels and symptoms are change significantly from week to week in pregnancy. In 
addition, women were sampled more than once in pregnancy, during the second and third 
trimesters, in only two of these studies (Jarnefelt-Samsioe et al., 1986; Lagiou et al., 2003).  
Other endocrine factors proposed to play a role in the development of NVP include 
progesterone, adrenal and pituitary hormones. One study found lower levels of 
progesterone among women who vomited in pregnancy (Jarnefelt-Samsioe et al., 1986), 
two other studies found no difference in progesterone levels and NVP (Lagioue et al., 2003; 
Masson et al., 1985), and one study reported higher levels of progesterone in women with 
hyperemesis gravidarum (Yoneyama et al., 2002). Few reports have examined adrenal, and 
pituitary hormones and currently there is no conclusive evidence implicating either of them 
(Borgeat, Fathi, & Valiton, 1997).  
Theories regarding beneficial effects relate NVP to safe digestive behaviours. Certain 
foods, caffeinated beverages and alcohol may be teratogenic and it has been suggested 
that pregnant women are sensitized to vomit by persistent nausea in order to protect the 
developing fetus in early pregnancy (Profet, 1988). Flaxman and Sherman (2000) 
hypothesized that women with NVP tend to avoid animal products that are more likely to 
harbor parasites or other pathogens that could potentially endanger their health and the 
health of the developing fetus. Food aversions to meat, fish, eggs, and fatty foods are 
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common and this pattern is consistent with the ethnographic evidence of little or no NVP in 
population groups relying on grain and plant-based diets. In addition, many women with 
NVP also complain of an increased sense of smell (Swallow, Lindow, Masson, & Hay, 
2005), which may lead to aversion of noxious or toxic substances in pregnancy. However, 
an increased sensitivity to certain smells and tastes frequently triggers nausea in these 
women and is no longer protective when nausea and vomiting results. 
It has been speculated that NVP might be a response to infection. Five women with 
HG who did not respond to standard HG management reported complete relief of symptoms 
after Helicobacter pylori management (El Younis, Abulafia, & Sherer, 1998; Jacoby & 
Porter, 1999). However, there are no randomized controlled trials evaluating the efficacy of 
this treatment strategy to date.  
A genetic influence is supported by observations that NVP shows ethnic variation 
(Minturn & Weither, 1984), is more frequent in monozygotic twins (Cory, Berh, Solaas, & 
Nance, 1992), is more common in women whose sisters and mothers are affected (Gadsby, 
Barnie-Adshead, & Jagger, 1993), and is associated with genetically determined conditions 
such as taste sensation (Sipiora, Murtaugh, Gregoire, & Duffy, 2000) and glycoprotein 
receptor defects (Akerman, Zhenmin, Rao, & Nakajim, 2000; Rodien et al., 1998). Genetic 
predisposition may also a explain link between a history of migraine headaches and the 
increased risk of hyperemesis gravidarum (Heinrichs, 2002).  
Common gastric changes during pregnancy include decreased gastric emptying and 
lowered esophageal pressure (Walsh, Hasler, Nugent, & Owyang, 1996). Gastric changes 
may exacerbate NVP, but are unlikely the sole cause of the condition (Nelson-Piercy, 1997). 
History of motion sickness has also been associated with NVP (Whitehead et al., 1992) and 
suggests that a pregnancy stimulus may lower the threshold for vestibular mediated nausea 
and vomiting in some women.  
Early theories attributed more severe nausea and vomiting and psychological conflict 
regarding the pregnancy; however, most studies suggesting this link are older and have 
flawed methodologies that discredit the findings. The finding that women with NVP are more 
hypnotizable (Apfel, Kelly, & Frankel, 1986) led researchers to suggest that vomiting may be 
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a conditioned response to specific environmental cues, just like chemotherapy patients who 
develop anticipatory vomiting.  
2.3 Outcome  
 2.3.1 Fetal. A review of the literature did not reveal an increased incidence of 
congenital malformations reported in children born to women affected by NVP (Klebanoff & 
Mills, 1986). Several studies suggest that NVP is a favorable prognostic sign, with a 
decreased risk of miscarriage, preterm delivery, low birthweight, stillbirth and fetal and 
perinatal mortality (Czeizel & Puho, 2004; Weigel & Weigel 1989), although later studies 
have challenged these claims (Louik, Hernandez-Diaz, Werler, & Mitchell, 2006). 
Hyperemesis gravidarum has been linked to fetal growth restriction (Chin & Lao, 1988; 
Gross, Librach, & Cecuti, 1989) and Wernickeʼs encephalopathy resulting in fetal death in 
40% of cases (Rotman, Hassin, Mouallem, Barkai, & Farfel, 1994).  
Few studies have examined the long-term effects of NVP on child development. 
Nausea and vomiting in the second and third trimesters of pregnancy has been found to be 
associated with effects on childʼs emotions, increased motor activity, and attention and 
learning problems at 12 years of age (Martin, Wisenbaker, & Huttunen, 1999). Interestingly, 
one study reported an association between NVP and improved neurodevelopment in the 
offspring (Nulman et al., 2009). Children aged 3 to 7 born to mothers with NVP had 
significantly higher nonverbal intelligence, verbal processing, and forward digit span scores. 
The authors also found that exposure to diclectin did not adversely affect childrenʼs 
cognitive abilities, which is congruent with other reports of no adverse morphological effects 
of the doxylamine-vitamin B6 combination in women with NVP (Huxley, 2000; Sherman & 
Flaxman, 2002; Weigel & Weigel, 1989).   
2.3.2 Maternal. Before the availability of modern treatments, severe NVP was 
important contributor to maternal mortality (Sonkusare, 2008). While rarely life threatening 
now, women report considerable physical and psychological effects with altered family, 
social or occupational functioning (Attard et al. 2002; Chou, Lin, Cooney, Walker, & Riggs, 
2003; Chou, Kuo, & Wang, 2008; OʼBrien & Naber,1992; OʼBrien, Relyea, & Lidstone, 1997; 
Swallow, Lindow, & Masson, 2004). The misery associated with persistent nausea and 
vomiting and the serious disruption to everyday life are often underestimated by care 
10 
providers (Attard et al., 2002; OʼBrien & Naber, 1992), and woman have reported that they 
would like their symptoms and resulting suffering acknowledged to a greater extent (Locock, 
Alexander, & Rozmovits, 2008).  
The socioeconomic burden of NVP on women and society is substantial. The 
complete spectrum of NVP results in 47% to 50% of working women with NVP believing that 
their job efficiency is reduced (OʼBrien & Naber, 1992; Vallacott, Cooke, & James, 1988), 
35% lose work time (mean loss of 62 working hours per woman) (OʼBrien & Naber), and 
25% lose time from housework (mean lose of 32 hours per woman (Gadsby, Barnie-
Adshead, & Jagger, 1993; Jarnfelt-Samsioe, Samsioe, & Velinder, 1983; Mazzota et al., 
2000, OʼBiren & Naber). Severe NVP is the most common cause of hospitalization in the 
first half of pregnancy and the second most common cause of antenatal hospitalization 
during pregnancy overall, second only to preterm labor (Gazmararian et al., 2002).  
Little is known about the long-term impact of NVP on mothers who bear the condition. 
Hyperemesis gravidarum and hospitalization during pregnancy have both been reported as 
factors related to Posttraumatic Stress Disorder (PTSD) after delivery (Maggioni, Margola, & 
Fillippi, 2006). Another study found that women with HG were more likely to report that 
recovery from their pregnancy took longer than 1 month and continued to report gallbladder 
dysfunction, food aversions, muscle pain, nausea, and symptoms characteristic of PTSD 
into the postpartum period (Fejzo et al., 2009). The authors suggest that food aversions 
may be the result of behavior modification over the months of pregnancy, and other 
symptoms may be a sign of the marked nutritional deprivation these women undergo.  
2.4 Determinants 
 Numerous reports have examined various treatments for NVP (Niebyl & Goodwin, 
2002; Mazzotta & Magee, 2000) or the relationship between NVP and pregnancy outcome 
(Klebanoff & Mills, 1986; Sherman & Flaxman, 2002), but few studies have considered risk 
factors for either the development or severity of NVP itself. Among those studies that have 
explored the correlates of NVP, no clear consensus has emerged. An overview of the 
studies comparing nausea and vomiting in pregnancy and psychosocial determinants of 
health is included in Appendix E. 
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 2.4.1 Sociodemographic. A review of the literature reveals that NVP is more 
common in Westernized civilizations, in predominantly urban compared with rural 
populations, and is rare in African, Native American, Eskimo, and some Asian populations 
except for the industrialized Japanese (Fairweather, 1968; Minturn & Weiher; Semmens, 
1971; Walker, Walker, Jones, Vervardi, & Walker, 1985). Living alone (Gertraude, Strunz-
Lehner, Egen-Lappe, Lack, & Hasford, 2007) or living in overcrowded or unfamiliar 
circumstances (Deuchar, 1995) are predictors for NVP. Some studies report that women 
who are younger (Klebanoff, Koslowe, Kaslow, & Rhoads, 1985; OʼBrien & Zhou), with a 
lower level of education (Klebanoff et al., 1985; Lacroix et al., 2000), and who are not 
working or who are housewives are more likely to have NVP (Kallen, Lundberg, & Aberg, 
2003). However, others have revealed that NVP affects all socioeconomic strata (Tierson, 
Olsen, & Hook, 1986) and may not be associated with education level (Fitzgerald, 1984; 
OʼBrien & Zhou, 1995) or age (Fitzgerald, 1984). 
2.4.2 Obstetrical/biological. Certain obstetrical and biological factors may also 
influence the development of nausea and vomiting in pregnancy. NVP is more common in 
women who are obese (OʼBrien & Zhou, 1995) and who have a history of nausea when 
taking estrogen-containing oral contraceptives (Järnfelt-Samsioe, Samsioe, & Velinder, 
1983). Prior infertility and a history of the condition in a previous pregnancy also increase 
the likelihood of NVP (Gadsby, Barnie-Adshead, & Jagger, 1997; Weigel & Weigel, 1988). 
In women seeking an abortion, ultrasound assessments revealed that vomiting was 
associated with corpus luteum on the right ovary, but not the left (Samsioe, Crona, Enk, & 
Järnfelt-Samsioe, 1986). The authors suggested that venous drainage, which differs 
between the right and the left side, might be responsible for the fact that the same woman 
can either suffer from or be free from nausea during pregnancy. NVP may increase in 
duration with each successive pregnancy (Einarson, Navioz, Matlepe, Einarson, & Koren, 
2007), although some women experience higher, lower, or similar incidences (Gadsby, 
Barnie-Adshead, & Jagger, 1993; Rhodes, 1990). Jarnfelt-Samsioe and colleagues (1983) 
reported that nausea was more pronounced in women with allergies, symptomatic 
gallbladder disease, or gastritits, but these concurrent conditions did not affect the duration 
of nausea. NVP appears to be uncorrelated with other complications of pregnancy, including 
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diabetes, hypertension, preeclampsia, anemia, and proteinuria (Jarnfelt-Samsioe et al.; 
Klebanoff, Koslowe, Kaslow, & Rhoads, 1985).  
Intriguingly, a female fetus is most often associated with NVP. Three studies have 
found and association between NVP and female offspring (Hsu & Witter, 1993; OʼBrien & 
Zhou, 1995; Vilming & Nesheim, 2000), although earlier studies disagree with this assertion 
(Vallacott, Cooke, & James, 1988; Whitehead, Andrews, & Chamberlain, 1992). Three 
studies have found an association between hyperemesis gravidarum and increased odds of 
having a female fetus compared with controls (Askling, Erlandsson, Kaijser, Akre, & Ekbom, 
1999; Kallen, 1987; Schiff, Reed, & Daling, 2004). The usual explanation for the increased 
incidence of female fetuses is related to higher estrogen concentrations. 
2.4.3 Psychological. Nausea and vomiting in pregnancy might be explained by 
recent evidence which supports biological pathways linking stress to body changes. 
Hormones that are involved in the stress response (e.g., adrenocortico-tropic hormone and 
cortisol) were positively correlated with the severity of nausea reported among pregnancy 
women (Otto, Riepl, Klosterhalfen, & Enck, 2006). Reactions to stress during pregnancy can 
be somatic and include vomiting (Morgan, 1985). Somatic complaints including vomiting 
have been reported more often in women with high levels of anxiety during pregnancy 
compared to pregnant women without anxiety (Martin, 1987). Emotionally disturbing events 
have also been associated with vomiting in pregnancy (Georgas, Giakoumake, Georgoulias, 
Koumandakis, & Kaskarelis, 1984). Based on a ʻspecially constructed questionnaireʼ 
administered to 102 women in the first trimester, NVP were associated with stress, lack of 
information about pregnancy, childbirth and health of the fetus, and poor communication 
with the husband and physician (Iatrakis, Sakellaropoulos, Kourkoubas, & Kabounia, 1998). 
On the other hand, studies have found no differences in marital status, whether the infant 
was planned, or positive feelings about the pregnancy between women with and without 
nausea and vomiting in pregnancy (Vallacott, Cooke, & James, 1988; Wolkind & Zajicek, 
1978). The rapid improvement of some women on admission to hospital and consequent 
removal from a stressful home environment (American College of Obstetricians and 
Gynecologists, 2004) suggests that stressors and maternal coping skills may play a role in 
the development of NVP. Having a supportive relationship with either a partner, mother, or 
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friend has been shown to mediate both stress (Chou, Avant, Kuo, & Fetzer, 2008; Chou, 
Kuo, & Wang, 2008) and anxiety in pregnancy (Jesse, Walcott-McQuigg, Mariella, & 
Swanson, 2005), although the effect of social support on NVP is less understood. 
Mood changes and depression have been associated with nausea and vomiting in 
pregnancy. Women who experience NVP report occurrences of tearfulness, irritability, 
lowered mood, sleep disturbance that undermined their self-esteem (OʼBrien & Naber, 1992; 
Deuchar, 1995). When quality of life measures are used in research studies, the scores for 
women with NVP are worse than the scores of women who report chronic depression 
(Attard et al., 2002). A diagnosis of depression in pregnancy is difficult due to the similarity 
in symptoms between the two conditions. Nonetheless, depression has been reported to 
affect up to 20% of pregnant women (Marcus, Flynn, Blow, & Barry, 2003) and nausea and 
vomiting have been independently associated with anxiety (Andersson, Sundstrom-
Poromaa, Wulff, Astrom, & Bixo, 2004; Swallow, Lindow, Masson, & Hay, 2004) depression 
(Chou, Lin, Cooney, Walker, & Riggs, 2003; Kitamura, Sugawara, Sugawara, Toda, & 
Shima, 1996; Mazzotta et al., 2000) and social dysfunction (Swallow et al., 2004) in 
pregnancy. While these studies clearly associate NVP with psychological morbidity, the 
temporal relationship is unclear, for example, if depression in pregnancy preceded or 
resulted from nausea and vomiting.  
Historically there was thought to be an association between NVP and psychological 
conflict regarding the pregnancy, although the finding has never been corroborated. This 
perspective stems from the favorite Freudian diagnosis of hysteria. Vomiting was viewed as 
an attempt to expel the unwanted fetus orally (Katon, Ries, Bokan, & Kleinman, 1980) and 
also represented a physical rejection of the woman to accept the transition into motherhood, 
symbolized the womanʼs relationship with her husband, and was even a means of the 
woman rejecting her own mother (Pines, 1990). Psychoanalysts have characterized women 
suffering from NVP as emotional, attention-seekers, seductive, dependent, helpless, self-
dramatizers, and with chameleon-like personality and sexual problems (Buckwalter & 
Simpson, 2002). A link between pathological personality types and NVP has never been 
proven and the concept that NVP reflects a conversion disorder has most likely impeded the 
progress toward a greater understanding of the condition (American College of 
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Obstetricians and Gynecologists, 2004). More recent studies have suggested that 
psychological symptoms are the result of the stress and the burden of daily and persistent 
nausea and vomiting rather than the cause (Verberg, Gillott, Al-Fardan, & Grudzinskas, 
2005). It has also been suggested that psychologic responses to the physiologic stimuli 
could become entrenched or conditioned with the 2 interacting to exacerbate NVP 
(Buckwalter & Simpson, 2002), thus interventions aimed at treating psychological symptoms 
might be helpful.  
2.4.3 Behavioural. FitizGerald (1984) reported an association between NVP and 
unintended pregnancy, although two other studies found no difference in whether or not the 
infant was planned (Vallacott, Cooke, & James, 1988; Wolkind & Zajicek, 1978). Women 
who are not actively planning their pregnancy may be more likely to experience NVP as 
early multivitamin supplementation has been linked to a decrease in risk of the condition 
(Kallen, Lundberg, & Aberg, 2003).  
Similar to women with depression, women with unintended pregnancies are less 
likely to start prenatal care early and are more likely to use cigarettes, alcohol, and drugs in 
pregnancy (Hellerstedt et al., 1998; Naimi, Lipscomb, Brewer, & Gilbert, 2003; Zuckerman, 
Amaro, Bauchner, & Cabral, 1989). Women who use drugs during pregnancy are more 
likely to be depressed, have fewer social supports, less stable living arrangements, and are 
more likely to smoke and drink alcohol (Lindenberg, Alexander, Gendrop, Nencioli, & 
Williams, 1991; Robins & Mills, 1993). Prenatal smoking was found decrease the chance of 
having vomiting (Klebanoff et al., 1985) or both nausea and vomiting in early pregnancy 
(Kallen, Lundberg, & Aberg, 2003; Weigel & Weigel, 1988). Alcohol consumption has been 
associated with a decreased probability of nausea and vomiting in early pregnancy (Little & 
Hook, 1979) as well as with increased stress levels after 20 weeks in gestation (Lindseth & 
Vari, 2005). Lacroix et al. (2000) did not find that cigarette and alcohol use in pregnancy 
were associated with nausea and vomiting, although other studies report an association 
with cigarette and alcohol use and emotional problems during pregnancy (Stewart & Steiner, 
1994).  
There is an abundance of literature on the negative effects of cigarette (US 
Department of Health and Human Services, 1990), alcohol, and drug use (Allen & Feeney, 
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1997), as well as unintended pregnancy (Brown & Eisenberg, 1995) on the health of the 
mother, the fetus, and future child. Whether or not cigarette and alcohol use are associated 
with NVP or are reflective of the amount of stress experienced by the pregnant woman 
warrant further exploration. 
2.5 Prevention 
 A randomized double-blind controlled trial of peri-conceptional multivitamin 
supplementation prior to 6 weeks gestation found a significant decrease in the rate of 
moderate nausea and vomiting in pregnancy. There was also a significant reduction in the 
occurrence of hyperemesis gravidarum, 3% in the supplemented group versus 6.6% in the 
unsupplemented group (Czeizel, 1996). Therefore, all sexually active women of childbearing 
age should be encouraged to take a multivitamin prior to known pregnancy for prevention of 
nausea and vomiting of pregnancy. 
2.6 Treatment 
The approach to treatment of NVP focuses on reducing the symptoms, while 
minimizing the maternal and fetal risks of antiemetic or non-medication measures. In the 
absence of a standardized assessment tool, the best assessment of the degree of 
symptoms is to ask the woman to share her view of the illness. Early intervention is thought 
to decrease the severity and duration of NVP, prevent complications, and likely improves 
the quality of life for the pregnant woman and her family. Thus, women with mild or 
moderate symptoms should be counseled early in their pregnancy on safe and effective 
treatments, as well as provided reassurance regarding the teratogenic risk of antiemetic 
medications in early pregnancy (Arsenault & Lane, 2002).  
2.6.1 Dietary and lifestyle modifications. Alterations to diet and lifestyle are 
common first line interventions for pregnant women with less severe nausea and vomiting. 
Although there are no clinical trials of these recommendations, women have reported that 
these measures can be beneficial in reducing the severity of NVP (Chandra, Magee, 
Einarson, & Koren, 2003; OʼBrien & Naber, 1992). In a recent international survey of 765 
women with HG, 22% reported that dietary changes were either maybe effective or effective 
in relieving their symptoms (Goodwin et al., 2008).   
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 Common dietary and lifestyle recommendations include small, dry, bland, frequent 
meals rich in easily digestible carbohydrates (e.g., soda crackers, biscuits), and avoidance 
of fibrous, spicy and fatty foods. Pregnant women are encouraged to eat whenever they feel 
hungry, as nausea is likely to be less severe at that time. Eating before rising in the 
mornings and eating a high-protein snack before going to bed may reduce symptoms. 
Drinking fluids can exacerbate nausea (Jewell & Young, 2003); therefore, drinking small 
amounts regularly between meals may help maintain hydration. Sleep requirements 
increase in early pregnancy (Santiago, Nolledo, Kinzler, & Santiago, 2001) and fatigue 
seems to exacerbate NVP (Chou et al., 2003). Therefore, pregnant women should increase 
their rest and lie down when feelings of nausea occur. They should also avoid smells, foods, 
and activities or situations (e.g., time spent in the kitchen) that they find nauseating 
(Ornstein, 1995). Lastly, any iron supplements should be temporarily discontinued as they 
can cause nausea, vomiting, and epigastric pain in some women.  
2.6.2 Antiemetics. Antiemetic therapy should be considered in women who have 
continued nausea and vomiting despite dietary and lifestyle changes. Medications that have 
been found to be safe and effective include dopamine antagonists (metoclopramide and 
domperidone) (Milkovich & Van Den Berg, 1976), phenothiazines (chlorpromazine and 
prochlorperazine (Godet & Marie-Cardine, 1991) and histamine H1 receptor blockers 
(promethazine and cyclizine) (Seto, Einarson, & Koren, 1997). However, both pregnant 
women and their doctors fear the possibility of medications affecting the development of the 
fetus and effective medications for nausea are often underutilized in early pregnancy (Koren 
& Levichek, 2002; Ornstein, 1995).  
Teratogenicity concerns primarily stem from the thalidomide tragedy in the early 
1960ʼs. Thalidomide was a drug held responsible for babies born with phocomelia, resulting 
in shortened, absent, or flipper-like limbs (McCredie, 1973). In 1983, extensive litigation 
concerning allegations of the teratogenicity of Benedictin  (vitamin B6-doxylamine), despite 
the lack of evidence to substantiate these claims, led the manufacturer to voluntarily 
withdraw the drug from the market (Pastuszak, 1995). Following this withdrawal, the rate of 
hospitalizations for women with NVP doubled during the next eight years in Canada and 
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similar trends were seen in the US. (Pastuszak, 1995). Currently Benedictin is available in 
Canada, but remains off the US market (Brent, 2002). 
2.6.3 Alternative therapies. Ginger, chamomile, peppermint, and red raspberry leaf 
tea are the most commonly cited herbal remedies from nonmedical sources of advice for 
“morning sickness” (Wilkinson, 2000). Only the effectiveness of ginger (1g/day) has been 
studied under randomized controls. Powdered root of ginger given to 30 women was 
significantly better than the comparison group at diminishing or eliminating symptoms of 
hyperemesis gravidarum (Fisher-Rasmussen, Kjaer, Dahl, & Asping, 1990). Ginger is a 
nonregulated food product and is available in a number of forms such as tea, biscuits, 
confectionary, and crystals or sugared ginger, although the purity and concentrations of 
most forms is uncertain. As the possibility of teratogenicity has not been excluded, large 
quantities of ginger should not be recommended as a treatment for NVP (Arsenault & Lane, 
2002). 
 More and more pregnant women are increasing interested in acupuncture and 
acupressure measures for relief of NVP. These measures involve stimulation of the P6 
Neiguan point located three-fingersʼ breadth proximal to the wrist, between two easily 
palpated tendons. Acupuncture requires a trained practitioner to insert thin needles over this 
site, whereas acupressure involves stimulation of the point either manually (using fingers or 
thumbs) for 5 minutes every 4 hours, or with wristband devices that provide steady pressure 
from a small button on the site. According to the American College of Obstetricians and 
Gynecologists (2004), evidence supporting or refuting acupuncture and acupressure is 
mixed. However, the safety of these measures has not been called to question and manual 
acupressure is readily available and without cost. 
2.6.4 Psychological support. It is common for mood disorders to accompany NVP, 
along with tearfulness and sleep disturbances (OʼBrien & Naber, 1992; Deuchar, 1995. 
Anxiety and depression may require treatment with safe therapeutic medications, such as 
antidepressants. Although tricyclic antidepressants (amitriptyline, nortriptyline, and 
imipramine) have shown no teratogenic effects when used in the first trimester (Nulman et 
al., 1997), their narrow therapeutic index, life-threatening cardiotoxicity in overdose, and 
severe anticholinergic effects make them less appealing (Arsenault & Lane, 2002). On the 
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other hand, selective serotonin re-uptake inhibitors (fluoxetine, fluvoxamine, paroxetine, 
sertraline, citalopram) are effective, not cardiotoxic, are safe even if used in excess (with the 
exception of citalopram) (Arsenault & Lane), and are not associated with an increased risk 
for major malformations when used in the first trimester (Marcus, Barry, Flynn, Tandon, & 
Greden). When women do not respond to medical and supportive care, psychiatric 
consultation is recommended (Hod, Orvieto, Kaplan, Friedman, & Ovadia, 1994).  
Psychotherapy, hypnotherapy, and behavioural therapy have been reported to 
diminish the symptoms of hyperemesis gravidarum (Iancu, Kotler, Spivak Radwan, & 
Weizman, 1994). Supportive counseling or enlisting the support and understanding of close 
friends and family in order to deal with the personal distress and social or occupational 
disruption from NVP may also be of benefit (Deuchar, 1995; Hod, Orvieto, Kaplan, 
Friedman, & Ovadia, 1994). The purpose of supportive therapy is not to develop deep 
insights into the psychological factors contributing to the condition, but rather to develop 
commonsense, practical approaches to the problem through encouragement, explanation, 
reassurance, and the opportunity to vent emotions (Deuchar, 1995).   
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Chapter 3 
Theoretical Perspectives 
 The purpose of this chapter is to describe the theoretical perspective that has guided 
this research. The underlying perspective is a population health approach that recognizes 
the interaction of multiple influences that shape the health of populations. 
3.1 Population Health Approach 
Population health is a perspective that focuses on the entire range of individual and 
collective factors and the interactions among them that determine health and well-being 
over the life course (Public Health Agency of Canada, 2005). These factors are referred to 
as determinants of health and currently include: income, supports, education, employment, 
social environment, physical environment, personal health practices and coping skills, 
healthy child development, biology and genetic endowment, health services, gender, and 
culture (Public Health Agency of Canada). The goal of population health is to improve the 
health of the entire population at every stage of life and reduce health inequities among 
different groups of people (Shah, 2003). Health inequalities refer to the broad determinants 
of health that are different at different social strata (Kindig & Stoddart, 2003). By focusing on 
determinants of health, policies and services are directed toward improving the overall 
health status of the population (Public Health Agency of Canada, 2005). 
Population health lends a different way of understanding health and may have more 
impact than the traditional biomedical model (Public Health Agency of Canada, 2005). 
Health involves emotional, social and physical well-being and is determined by the social, 
political and economic context of their lives, as well as by biology (Health Canada, 2003). 
This perspective broadens the scope of what it means to be healthy and differs from the 
traditional modelʼs narrow focus on individuals that were already sick or those that were at 
the greatest risk of developing a health problem. The population health perspective focuses 
on the existing health inequalities and complexities of womenʼs lives and is therefore a 
fitting approach to the study of nausea and vomiting in pregnancy. Moreover, a lack of 
attention to health inequalities has led to a systematic devaluation and neglect of womenʼs 
health (Sen & Östlin, 2008). 
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Nausea and vomiting in pregnancy is a multifaceted condition and several 
determinants may aggravate its presence and severity. Previously identified determinants 
include: genetic (American College of Gynecology Practice Bulletin, 2004), physiological 
(Goodwin, 2002), and biological factors (Ornstein et al., 1995; Huxley, 2000; Sherman & 
Flaxman, 2002); social characteristics, including stress, lack of social support (Chou et al., 
2003; Paalberg et al., 1996), environment, work status, and certain anxious attitudes or 
beliefs about the fetus or about pregnancy and motherhood (Atanackovic, Koren, & Magee, 
2000); behavioural factors including unintended pregnancy (FitzGerald, 1984), maternal 
smoking and alcohol consumption (Barkai et al., 1994; Weigel & Weigel 1989; Zhou, 
OʼBrien, & Relyea, 1999), and the psychological factors of anxiety and depression 
(Anderson et al., 2004; Chou, 2003; Kitamura et al., 1996; Mazzotta et al., 2000). However, 
as the literature revealed, the evidence is varied and at times contradictory due to the varied 
factors associated with nausea and vomiting in pregnancy.   
For this study, a population health approach has been used to examine nausea and 
vomiting as well as the risk factors and correlates of moderate and severe symptoms in 
pregnant women during two gestational time points. A conceptual model, shown in Figure 
3.1, was constructed based on the theory of population health (Public Health Agency of 
Canada, 2005) and adapted from the model titled, Determinants of Antenatal Depression 
and the Fetus, developed by Bowen (2007) for her study on the prevalence and 
determinants of antenatal depression among high-risk women in Saskatoon, Saskatchewan, 
Canada. Physiological factors that interrelate with determinants to affect the duration and 
severity of nausea and vomiting in pregnancy are included in the conceptual model. The 
anticipated determinants of nausea and vomiting are grouped and named as 
sociodemographic, obstetrical/biological, psychosocial, and behavioural. Each determinant 
is discussed in more detail, in relation to how they are measured in this study, in Section 
4.7.1 to 4.7.4 of Chapter 4. By exploring these determinants the resulting knowledge may 
be used to try to explain womenʼs susceptibility for nausea and vomiting in pregnancy. 
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Figure 3.1. The Population Health Approach Illustrating the Interrelated Determinants of 
NVP  
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Chapter 4 
Methodology 
 The chapter describes the study location, design, population and setting, inclusion 
and exclusion criteria, and ethical considerations. Next the chapter details the outcome 
variable and independent variables of interest. Finally, the data preparation, analytical 
procedures, and limitations of the study are described. 
4.1 Study Location 
This study was conducted at the University of Saskatchewan, Saskatoon, 
Saskatchewan in the College of Nursing. 
4.2 Study Design 
The dataset used in this secondary analysis was a sub-set of a larger clinical 
database of Canadian pregnant women enrolled in a longitudinal study of antenatal and 
postnatal depression called, The Feelings in Pregnancy and Motherhood Study (FIP), in 
Saskatoon, Saskatchewan, Canada between November 2005 and December 2008. The co-
principal investigators of the FIP study, Dr. Nazeem Muhajarine and Dr. Angela Bowen, 
were supported for three years under the Canadian Institutes for Health Research (CIHR) 
strategic research priority, Analyzing and Reducing Health Disparities (Grant #145179). The 
FIP study included a cohort of 649 pregnant women interviewed on three different 
occasions, in early and late pregnancy, and once again after their babies were born for the 
purposes of examining depression and its correlates in pregnant and early postpartum 
women.  
4.3 Population and Setting 
Participants from the original study spoke English and were recruited from 
physicianʼs offices or responded to poster, newspaper, and radio advertising. 
4.4 Inclusion and Exclusion Criteria 
The dataset used for this secondary analysis was restricted to women who 
completed the NVPI questionnaire after 5 weeks gestation, coinciding with the usual onset 
of nausea, vomiting and retching in pregnancy. The objective measure of NVP was added to 
the questionnaire after study commencement and participants who did not complete the 
measure were removed from the dataset. No pregnant woman refused to complete the 
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questionnaire once the NVPI measure was added. However, 40 women miscarried or 
delivered prior to data collection during the second time point and were removed from the 
dataset. Therefore, the dataset analyzed in this study contained 551 participants at Time 1, 
and 575 participants at Time 2.  
4.5 Ethical Considerations 
 The FIP study received ethical approval from the University of Saskatchewan and 
participating health regions prior to study commencement. On August 12, 2009, the 
Behavior Research Ethics Board of the University of Saskatchewan approved this 
secondary analysis of the FIP dataset (see Appendix A).  
4.6 Outcome Variable 
The variable of interest for this study was nausea and vomiting in pregnancy as 
measured by the Nausea and Vomiting in Pregnancy Instrument (NVPI) (Swallow, Lindow, 
Masson, & Hay, 2002). Verbal reports of ʻslightʼ and ʻsevereʼ symptoms without definition 
were common in the literature and led to the development of a tool to define and quantify 
NVP (Swallow et al., 2002). This tool screens for nausea, retching and vomiting over a 1-
week time period, and addresses the very real misery of the woman who is severely 
nauseated throughout the day or who retches repeatedly but does not vomit.  
The NVPI is a 6-point Likert scale that includes 3 scales of nausea, retching and 
vomiting in the past week. The three items of the NVPI include:  
1. How often have you felt like being (nauseous) in the past week? 
2. How often have you retched (but without actually being sick) in the past week? 
3. How often have you been physically sick during the past week?  
Each item is scored on a six-point Likert scale: ʻnot at allʼ, ʻoccasionallyʼ, ʻ3-6 days during 
the weekʼ, ʻdailyʼ, ʻmore than once a dayʼ and ʻall the timeʼ. Scores range from 0, ʻnot at allʼ 
to 5, ʻall the timeʼ. The items are summed to form a NVPI severity score ranging from 0 to 
15. The measure is presented in Appendix C. 
Swallow et al. (2002) validated the ability of the three scales forming the NVPI to 
discriminate between different levels of NVP symptoms. The ʻnot at allʼ responses appeared 
to be an objective measure and at the other end of the scale, in five cases where the 
woman had been admitted to hospital with hyperemesis gravidarum the scores were 
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substantially above the mean. The instrument had acceptable internal reliability at two 
gestational time periods with a Cronbachʼs alpha coefficient of 0.76 and 0.82, respectively. 
The test-retest reliability was high, although only a small sample completed the instrument 
twice (0.83; 95% confidence intervals 0.71-0.90). 
 The NVPI is used as both a continuous and categorical variable in this analysis.  
Due to the negatively skewed distribution of the NVPI score at Time 1 and Time 2, the 
variable was collapsed into severity categories that allowed for a focus on pregnant women 
with more nausea and vomiting. Scores of zero were separated from the NVPI score while 
remaining scores were divided into three equal groups. Scores of zero were then added to 
the first group to form the group ʻnone/less than mild NVPʼ. The second and third tertiles, 
excluding scores of 0, were termed ʻmoderate NVPʼ and ʻsevere NVPʼ, respectively. 
4.7 Independent Variables: Determinants of NVP 
 4.7.1 Sociodemographic  
 Age. Age (years) was treated as continuous in this analysis. 
 Marital status. Women were categorized as non-partnered for the purposes of this 
study if they were single, divorced, or widowed and partnered if they were married or in a 
common-law relationship. 
 Ethnicity. Women who self-identified as Caucasian were categorized as such and 
women who self-identified as First Nations, Métis or other were categorized as Aboriginal or 
other in this analysis. 
Education. Education level was collected as a categorical variable. It was further 
collapsed into the following categories: having grade 11 or less, having a grade 12 
education, and attending or graduated from university or a post-secondary institution. 
 Employment. Women were categorized as working or not working for the purposes 
of this study. 
 Income. Family income was assessed through four categories: under $20,000 per 
year; $20,000 to $39,999 per year; $40,000 to $59,999 per year; and >$60,000 per year. 
Income assistance, social and band, was grouped with <$20,000 per year.  
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4.7.2 Obstetrical/biological  
Gestation. Gestation (weeks) was recorded by staff or calculated from the expected 
due date and the date of the interview. Gestation was treated as a continuous variable in the 
analysis. 
Gravida or total number of pregnancies. The actual number of pregnancies was 
used as both a continuous and categorical variable in the analysis. Categories included one 
pregnancy, two pregnancies, three pregnancies, four pregnancies, and five or more 
pregnancies. 
Parity or total number of live births. The actual number of viable and live-born 
children the mother has delivered was assessed through two categories: primiparous as 
defined as a woman who has given birth to one live infant, and multiparous as defined as a 
woman who has delivered more than one live infant.  
4.7.3 Psychological  
Stressors. From a list of specific sources of stress, women were asked to indicate 
with a check mark as many of the stressors that they were presently experiencing. Potential 
responses included: Pregnancy, Partner, Money, Children, Family, Where I live, Health of 
my baby, Birth of my baby, Own health, Work, School, and Other stressors. The 12 items 
were summed into one composite variable by assigning 1 to each positive response to a 
stressor and 0 to the negative responses. This summed variable was also categorized into: 
lowest (0-1 stressors), middle (2-3) stressors, and highest (4+ stressors) numbers of 
stressors. This was determined by attempting to create equal numbers of stressors for each 
of the three categories. 
Worry. The Cambridge Worry Scale (CWS) is a tool developed to determine the 
major worries of women during pregnancy (Stathem, Green, & Snowdon, 1993). The validity 
and reliability of the tool was confirmed in a longitudinal study of 1207 pregnant women 
(Green, Kafetsios, Statham, & Snodon, 2003), and a Swedish version of the CWS was 
validated in a sample of 200 pregnant women in Stockholm (Georgsson, Ohman, 
Grunewald, & Waldenstrom, 2003). Women indicated their response to 16 items on a 5-
point Likert scale with the anchors described as 1, not a worry, and 5, major worry. The 16 
items included: Housing, Money, Law, Partner, Family, Own health, Health of others, 
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Employment, Baby, Going to the hospital, Internal examinations, Birth, Coping with baby, 
Giving up work, Partner present at birth, and Miscarriage. Women also had the opportunity 
to add other concerns in an open-ended question following the scale coded as Other. The 
17 items were summed into one composite variable and treated as both continuous and 
categorical in this analysis. In addition, three potential items of worry were treated as a 
separate item: Own health, Baby, and Miscarriage. Each of these items were summed and 
divided into three equal categories: low (scores of 0 and first third), moderate (second third) 
and high (final third) worry in this analysis. The measure is presented in Appendix D. 
Support. Participants were asked whether they have someone from whom they 
received emotional support and, if so, were asked to indicate with a check mark those 
sources of support (partner, mother, friend, relative, or other) of whom they feel they can 
count on no matter what. The variable was divided into four groups: no support (0 support), 
low support (1 support), medium support (2 supports), and high support (3 or more 
supports). The groups no support and low support were combined for regression analysis.  
Moods up and down. Mood fluctuation is seen in people who are depressed 
(Bowen, Clark, & Baetz, 2004). Women were asked two questions including, whether or not 
their moods went up or down, and if they had mood swings that occurred for no reason. 
These questions were combined into a continuous composite variable and categorized into 
low moods up and down, moderate moods up and down, and high moods up and down. 
History of depression. This variable consisted of self-reported questions about the 
womanʼs history of depression, including antenatal and/or postnatal depression, and was 
treated as a dichotomous item. 
Depression. The Edinburgh Postnatal Depression Scale (EPDS) (Cox, Holden, & 
Sagovsky, 1987) includes 10 items on a Likert-like scale ranging from 0 to 3, for a maximum 
score of 30. Originally developed to assess postpartum symptoms, the EPDS has also been 
validated in prenatal samples (Adouard, Glangeaud-Freudenthal, & Golse, 2005). Using a 
cutoff score of 10, the EPDS has a sensitivity of 90% and specificity of 78-88% for the 
identification of both minor and major depression (Gaynes et al., 2005; Adouard et al., 
2005). Previous research with similar samples of pregnant women has found that when 
using a cutoff of 10, 74% of women met diagnostic criteria for depression using the Mood 
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Disorders Module of the Structured Clinical Interview for DSM-IV (SCID) (Flynn, OʼMahen, 
Massey, & Marcus, 2006). 
An EPDS score of 10 or more (≥10) represents minor depression (Horowitz et al., 
2001) and a cut-off score of 13 or more (≥13) has been validated and recommended for 
detecting major depression in pregnancy (Murray & Cox, 1990) and is used most often to 
report the prevalence of major depression in antenatal women in the literature (Da-Silva, 
Moraes-Santos, Carvalho, Martins, & Teixeira, 1998). Thus, a score of ≥13 was used to 
determine and report the prevalence of major depression in this study. In this analysis, the 
EPDS was used as a continuous variable. It was also dichotomized into two separate 
derived variables: minor depression as defined by EPDS score greater or equal to 10, and 
major depression as defined by EPDS scores greater or equal to 13. The measure is 
presented in Appendix E. 
Anxiety. The EPDS may not measure a single expression of mood or depression. A 
depression subscale (items 1, 2, and 8) and an anxiety subscale (items 3, 4, and 5) have 
been identified in the EPDS in women in pregnant and postpartum women (Brouwers, van 
Baar, & Pop, 2001). The validity of the EPDS as a tool to identify anxiety was affirmed by 
Stuart, OʼHara and Blehar (1998) who found a strong correlation between the State Anxiety 
Scale of the State-Trait Anxiety Inventory and the EPDS (r=0.73 at 14 weeks postpartum, 
r=0.82 at 30 weeks postpartum, n=107). Brouwers et al. (2001) also tested the validity of the 
EPDS for measuring anxiety and depression (2001), and they confirmed the presence and 
validity of the subscales but found the overall EPDS most accurately measured both 
depression and anxiety.  
Items 3, 4 and 5 of the EPDS were summed to form one composite variable. A score 
of 4 or greater represents possible anxiety. The variable was treated as both continuous 
and categorical in this analysis.   
4.7.4 Behavioural  
Unintended pregnancy. Women were asked if they had planned their pregnancy. 
This question had a yes or no choice for response but also included a response of ʻsort ofʼ 
which was coded as ʻyesʼ for the analysis. 
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Smoking. Participants were asked if they smoked, if they had ever smoked, the 
amount smoked per day in the last month, or if they had quit before or since becoming 
pregnant. Smoking was recoded into three categories: never smoked, current smoking, or 
quit smoking (before or during pregnancy) for analysis.  
Alcohol use. Alcohol use was determined using questions that encompass the risk 
criteria for Fetal Alcohol Spectrum Disorder (FASD): e.g., drinking 5 or more drinks at one 
sitting (binge drinking), and drinking 1-2 drinks every day in the last month, or if they had 
quit using alcohol during or before pregnancy (Public Health Agency of Canada, 2004). 
Women could mark a check for more than one category (e.g., occasional drink and binge 
drink). The variable was recoded into three categories of alcohol use: never used, current 
use, or quit use (before or during pregnancy). 
Substance abuse. Participants were asked how often they had used illicit drugs 
such as cocaine, crystal methamphetamine, and marijuana in the past month or if they had 
quit during or before pregnancy. The variable was recoded into three categories: never 
used, current use, or quit use (before or during pregnancy). 
 4.7.5 Potential confounding factors 
 A confounding factor is an independent factor that distorts the association between 
another independent factor and the outcome of interest, as it is related to both (Agresti, 
2002).  
Antiemetic medication. Women were assessed for use of medications for nausea 
and vomiting in pregnancy. Antiemetic mediation was treated as a dichotomous variable.  
 Psychotropic medication. Women were assessed for anxiety, depression, and 
antipsychotic medications. Psychotropic medication use was treated as a dichotomous 
variable. 
4.8 Data Preparation  
 Variables of interest were transferred from a Statistical package for Social Sciences 
(SPSS ver. 18.0 for Macintosh) system file. Data were cleaned and edited using frequency 
runs to check for errant and unusual values as well as logical inconsistencies. These 
inconsistencies were then checked against the original questionnaire and resolved with the 
assistance of the co-principal investigator and research assistant of the original study.  
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4.9 Analytical Procedures 
 The method of analysis is reported by each research question to address the 
hypothesis outlined in section 1.2. 
 4.9.1 Question 1. What is the prevalence of nausea and vomiting at two gestational 
time points in this sample of pregnant women and is this prevalence different from rates 
reported in the literature? 
Analysis. Following data preparation, descriptive statistics including the mean, 
mode, median, interquartile range, standard deviation, and frequencies were assessed on 
each continuous variable and frequencies and percentages were assessed for categorical 
factors at both time periods (Time 1 and Time 2).  
The distribution of the dependent variable was assessed and dichotomized to 
determine the prevalence of nausea and vomiting (no symptoms versus having NVP) at 
both time periods. In order to determine the prevalence for severe and moderate nausea 
and vomiting, participants with a NVPI score between 1 and 15 were divided into three 
equal groups. None and mild NVP was then defined as a NVPI score of zero plus the first 
third. Moderate NVP was defined by the second tertile (excluding scores of zero), and 
severe NVP was defined as the third tertile (excluding scores of zero).  
In addition, to the prevalence for severe and moderate nausea and vomiting at both 
time periods, prevalence was also determined in pregnant women who experienced either 
of these symptoms at Time 1 and continued to have moderate or severe NVP at Time 2. 
Data between participants were compared for differences by using Crosstabs. Wilcoxon-
Sum Ranks test were performed to assess the degree of difference across both time 
periods between each of the scale indices: nausea, retching, and vomiting; as well as the 
total NVPI score.  
Differences in psychological determinants between Time 1 and Time 2 were also 
examined. Women who completed the NVPI at both time periods (n=511) were matched for 
analysis. Paired observations of continuous variables were analyzed with the Wilcoxon 
signed ranks test. One continuous psychological variable, worry, was excluded from 
analysis as a result of its sum of negative ranks equaling the sum of its positive ranks. 
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4.9.2 Question 2. What sociodemographic, biological/obstetrical, psychological, 
and behavioral determinants are associated with moderate and severe nausea and vomiting 
at Time 1 in this group of pregnant women? 
Analysis. Descriptive analyses were performed on each determinant at Time 1 and 
Time 2. Bivariate analyses using binomial statistics were then performed with the 
categorical dependent variable (Agresti, 2002). A series of logistic regressions each 
containing a single independent variable was conducted to obtain Odds Ratios (OR), 95% 
Confidence Intervals (CI), and p-values for each determinant.  
Determinants which had bivariate associations at p-value significance ≤ 0.25 were 
then entered into a logistic regression procedure to determine the final model for moderate 
and severe NVP in each of the determinants (sociodemographic, biological/obstetrical, 
psychological, and behavioural). However, following this criterion for the final model would 
have resulted in a large number of variables, greater than the recommended 10-15 (Hosmer 
& Lemeshow, 2000). Therefore, only those variables with a bivariate association significant 
at ≤ 0.10 were entered stepwise into the final logistic regression. Factors that were 
considered to be potentially confounding, including antiemetic and psychotropic 
medications, were also entered in the final model. 
Variables in the final model for moderate and severe NVP at Time 1 were tested for 
interaction, linearity of the logit, independence of errors, and multicollinearity. For variables 
perceived to measure the same concept, a 10% difference was used to determine the 
presence of confounding (Menard, 1995; Myers, 1990). All cases were included in the initial 
model and agreement between observed and fitted values was determined with the 
goodness-of-fit test (Hosmer, Hosmer, Cessie, & Lemeshow, 1997). Next, outliers and 
influential cases were identified and solutions without these cases were interpreted where 
these cases were found to be unduly influencing the fit of the data. A 0.05 criterion of 
statistical significance was used in the final model.  
In the final model, no interactions were present and the assumptions of logistic 
regression were satisfied. Multicollinearity among psychosocial correlates was not a 
concern. The goodness-of-fit test demonstrated that the baseline model was a good fit of 
the data. A combined total of 13 outlying and influential cases were identified and removed 
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from the data set before the analysis was repeated. When these cases were excluded there 
was little change in the overall fit of the data and only a 2.1% increase in accuracy 
compared to the baseline model was observed. Therefore the final model used for 
interpretation included all outlying and influential cases.  
4.9.3 Question 3. What sociodemographic, biological/obstetrical, psychological, and 
behavioral determinants are associated with moderate and severe nausea and vomiting at 
Time 2 in this group of pregnant women? 
Analysis. Similar analyses were done as in Question 2 for pregnant women at Time 
2. The NVPI total score at Time 1, collapsed into moderate and severe categories, was also 
included in the Time 2 model to explore the possible intercorrelation of more severe NVP 
symptoms at Time 1 and Time 2.  
In the final model, no interactions were present and the assumptions of logistic 
regression were satisfied. Multicollinearity among psychosocial correlates was not a 
concern. The goodness-of-fit test demonstrated that the model was a good fit of the data. A 
combined total of 17 outlying and influential cases were identified and removed from the 
dataset before the analysis was repeated. When these cases were excluded there was little 
change in the overall fit of the data and only a 4.9% increase in accuracy compared to the 
baseline model was observed. Therefore the final model used for interpretation included all 
outlying and influential cases.  
4.9.4 Question 4. What is the nature of the relationship between nausea and 
vomiting and psychological determinants, as well as antiemetic and psychotropic 
medications, as evidenced by two time points in pregnancy? 
Analysis. Differences in NVP severity and symptoms of major depression were 
compared among three different groups of woman. First, comparisons between 
psychotropic medication use and NVP severity were made with chi-square analysis for both 
time periods (n=551, 575). Similarly, comparisons between antiemetic medication use and 
symptoms of major depression (EPDS≥13) were also conducted. Finally, chi-square was 
also used to analyze women who completed the NVPI at both time periods (n=511) and who 
had symptoms of major depression at Time 1 but no longer had these symptoms at Time 2. 
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4.10 Limitations 
 The main limitations in this study focus on the measures used and secondary study 
design.  
4.10.1 Study tools. The Nausea and Vomiting in Pregnancy Instrument has been 
validated in the United Kingdom, a region where English is also the primary language. 
However, the tool remains to be validated in different settings and cultures. The NVPI was 
not validated in this particular population, in which 15.5% of the women were of Aboriginal 
ancestry. 
 4.10.2 Study design. Three limitations are noted regarding study design. First, the 
question used to measure mood fluctuation was asked during Time 1 but not asked during 
the second time point, thus we were only able to examine mood swings and nausea and 
vomiting in pregnant women for the first time point in this study. Second, the original survey 
did not record symptom onset and we therefore do not know when nausea and vomiting 
symptoms first occurred in this sample. Third, the lack of an additional time point either in 
pregnancy or postpartum limits the ability to establish causality or to explore further the 
nature of the relationship between health determinants and nausea and vomiting in this 
sample of pregnant women. 
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Chapter 5 
Results 
 This chapter presents a description of the study participants and the 
sociodemographic, biological/obstetrical, psychosocial, and behavioral determinants 
associated with nausea and vomiting in pregnancy. The chapter begins with a profile 
participant characteristics, followed by addressing the questions posed in the thesis; it 
presents the prevalence, comparative, and analytic findings for the data. Unless otherwise 
indicated, a significance level of p<0.05 was used to determine statistical significance. 
5.1 Participant Characteristics 
As Figure 5.1 depicts, approximately 649 women from the original study would have 
been potential participants during both time periods.  
 
Figure 5.1. Study Sample 
 
 
 
 
 
 
 
 
 
 
 
Potential subjects from the Feelings in Pregnancy 
& Motherhood Study 
n = 649 
 
Time 2 Eligible Participants 
3rd Trimester n = 575  
 
Time 1 Eligible Participants 
2nd Trimester n = 551 
  
Excluded for not completing the 
NVPI measure at Time 1  
n = 98 
Participants who miscarried or 
delivered prior to Time 2 
 n = 40 
Excluded for not completing 
the NVPI measure at Time 2 
n = 34 
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Five hundred and fifty one pregnant women were available for data analysis at Time 
1 and 575 women were available for analysis at Time 2. In total, these data represent 
84.9% and 88.6% of the original 649 participants during the period of the study. The 
sociodemographic, obstetrical/biological, psychological, and behavioural determinants are 
provided in detail in Tables 5.1 to 5.4. 
 Table 5.1 describes the sociodemographic characteristics of study participants. The 
majority of women in this group were between the ages of 25 and 34 (mean age 29.3 ± 
4.65), of Caucasian ancestry (84.5%), partnered (90.3%), and completed post secondary 
education (68.7%). 81% were working and 47.6% were living on an income greater than 
$60,000 per year. 
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Table 5.1. Sociodemographic Characteristics 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n % n % 
Age (years)     
   <20 18 3.3 14 2.5 
   20-24 72 13.1 69 12.0 
   25-29 210 38.1 223 38.9 
   30-34 177 32.1 194 33.6 
   35-39 68 12.3 68 11.8 
   >40 6 1.1 7 1.3 
Marital Status     
   Single 44 8.0 49 8.5 
   Common law 89 16.2 82 14.3 
   Married 411 74.6 437 76.0 
   Separated/divorced/widowed 7 1.3 7 1.2 
Ethnicity     
   Aboriginal//Métis/other 82 14.9 89 15.5 
   Caucasian 469 85.1 486 84.5 
Education     
   <Grade 8 1 0.2 1 0.2 
   Grade 9-12 24 4.4 21 3.7 
   Completed grade 12 70 12.7 65 11.3 
   Some post secondary 85 15.4 93 16.2 
   Completed post secondary 371 67.3 395 68.7 
Employment     
   Not working 111 20.1 109 19.0 
   Working 440 79.9 466 81.0 
Income (per year)     
   <$20,000 63 11.6 67 11.8 
   $20,000-$39,999 106 19.5 102 18.0 
   $40,000-$59,999 120 22.1 127 22.4 
   >$60,000 254 46.7 270 47.6 
   Other 1 0.2 1 0.2 
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Table 5.2 describes the obstetrical and biological determinants of the women. The 
average gestation of the pregnancy at the time women completed the questionnaires was 
17.6 weeks (± 5.1 weeks), with a range of 5 to 30 weeks at Time 1; and 30.7 weeks (± 2.6 
weeks), with a range of 23 to 39 weeks at Time 2. Gravidity ranged from 1 to 8 pregnancies 
(median 2.0 ± 2 pregnancies), approximately 38% of women were pregnant for the first time 
and 52.3% had yet to give birth to a live/viable infant. At Time 1, 25% of women reported 
moderate NVP and almost 24% reported severe NVP. 
 
Table 5.2. Obstetrical/Biological Characteristics   
 Time 1 (n=551) Time 2 (n=575) 
 n % n % 
Gestation (weeks) (Mean ± SD) 17.6 ± 5.10      30.7 ± 2.6 
Total number of pregnancies     
      1 211 38.3 218 37.9 
      2 182 33.0 197 34.3 
      3 94 17.1 97 16.9 
      4 37 6.7 36 6.3 
      5+ 27 4.9 27 4.8 
Live born children*       
    Nulliparous 291 53.0 301 52.5 
    Primiparous 176 32.1 186 32.5 
    Multiparous 82 14.9 86 15 
* Total does not equal to 575 due to missing data 
 
Table 5.3 describes the psychological health determinants. The cumulative stress 
score was an average of 2.48 ± 1.88 stressors at Time 1, and 2.23 ± 1.74 at Time 2. As 
Table 5.3 shows, most of the women experienced medium (2-3 stressors) to high levels of 
stressors (4+ stressors). Approximately 34% report the health of the baby as a stressor at 
Time 1. Over 35% report the birth of the baby as a stressor at Time 2. The cumulative worry 
score was an average of 28.76 ± 8.01 points at Time 1, and 28.77 ± 8.10 points at Time 2. 
Most of the women experienced medium (20-29 score) to high levels of worry (30+ score). 
Similarly to stressors, women report the health of the baby as middle to major worry 
approximately 73% at both time periods. Of the 90.3% of women who said they were 
married or in a common-law relationship, about 84% at Time 1 and 85% at Time 2 reported 
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their partner as a source of support. Over 98% of the women stated that overall they 
generally felt supported. The cumulative support score was an average of 2.73 ± 1.17 
supports at Time 1, and 2.60 ± 1.17 supports at Time 2. 
 Thirty-six percent of the women at Time 1 and 35% of the women at Time 2 had a 
history of depression. Approximately half of the women at Time 1 report moods going up 
and down; however, the question was not available for response on the Time 2 
questionnaire. The cumulative EPDS anxiety subscale score was 3.37 ± 2.06 at Time 1, and 
2.96 ± 1.93 at Time 2. Approximately 47% and 39% of women reported an anxiety subscale 
greater than or equal to 4 for both time periods, indicating possible anxiety. The cumulative 
EPDS score was 6.82 ± 4.57 at Time 1, and 6.24 ± 4.33 at Time 2. The prevalence of minor 
antenatal depressive symptoms (EPDS ≥ 10) in this sample, in the last seven days, was 
12.7% and 11.8% at both time periods, respectively Major depressive symptoms (EPDS ≥ 
13) were reported by 11.4 % and 7.8% of women at Times 1 and 2.  
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Table 5.3. Psychological Characteristics 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n* % n* % 
Stressor score     
    Lowest (0-1 stressors) 181 32.8 231 40.2 
    Middle (2-3 stressors) 238 43.2 234 40.7 
    Highest (4+ stressors) 132 34.0 110 19.1 
Specific stressors     
    No stressors right now 51 9.3 67 11.7 
    Pregnancy 115 20.9 136 23.7 
    Partner 98 17.9 65 11.3 
    Money 105 19.1 128 22.3 
    Children 105 19.1 85 14.8 
    Family 98 17.9 73 12.7 
    Where I live 72 13.1 45 7.8 
    Health of my baby 188 34.2 143 24.9 
    Birth of my baby 137 25.0 203 35.4 
    Own health 95 17.3 94 16.4 
    Work 225 41.0 145 25.3 
    School 38 6.9 31 5.4 
    Other 129 23.5 134 23.3 
Worry score     
    Lowest (0-19 score) 42 7.6 40 7.8 
    Middle (20-29 score) 306 55.5 285 55.8 
    Highest (30+ score) 203 36.8 186 36.4 
Own health worry score (0-5)     
    Lowest (0-1 worries) 245 44.5 269 46.8 
    Middle (2-3 worries) 261 47.4 269 46.8 
    Highest (4+ worries) 45 8.2 37 6.4 
Health of my baby worry score 
(0-5)     
    Lowest (0-1 worries) 148 26.9 157 27.4 
    Middle (2-3 worries) 308 56.0 326 56.8 
    Highest (4+ worries) 94 17.1 91 15.9 
Miscarriage worry score (0-5)     
    Lowest (0-1 worries) 219 39.7 260 45.2 
    Middle (2-3 worries) 250 45.3 244 42.4 
    Highest (4+ worries) 82 14.9 71 12.4 
Support score     
    No support 9 1.6 6 1.0 
    Low (1 support) 87 15.8 111 19.3 
    Medium (2 supports) 143 26.0 171 29.7 
    High (3+ supports) 312 56.5 287 48.0 
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Table 5.3. Psychological Characteristics (continued) 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n* % n* % 
Specific sources of support     
    Support in general 542 98.4 565 98.3 
    Partner 461 83.8 486 84.7 
    Mother 345 63.0 351 61.4 
    Friend 356 64.7 377 65.7 
    Female relative 249 45.3 259 45.1 
    Other (father, mother-in-law, 
etc.) 89 16.2 98 17.1 
Do your moods go up and down     
    Yes 275 49.8 ** ** 
History of Depression     
    Yes 196 35.6 202 35.1 
Anxiety(EPDS subscale ≥ 4)     
    Yes 258 46.8 222 38.6 
Mild Depression (EPDS ≥ 10)     
    Yes 70 12.7 68 11.8 
Major Depression (EPDS≥13)     
    Yes 63 11.4 45 7.8 
* Total may not equal 551 or 575 due to missing values 
** Question not included on questionnaire at Time 2 
 
 
Women who completed the NVPI at both time periods (n=511) were examined for 
differences in psychological determinants across both time periods. The results of the 
Wilcoxon signed ranks test indicated that the 511 pregnant women who completed the NVPI 
at both time periods significantly reduced their median EPDS levels (Md=6.0 to 5.0) (Table 
5.4) as their pregnancy progressed. A significant reduction was also noted for stressors 
(p=0.004) and anxiety (p=0.001) at Time 2. 
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Table 5.4. Wilcoxon Signed Ranks Analysis for NVPI and Psychological Determinants 
(n=511) 
 Mean Median SD p-value 
Stressors score total    0.004 
    Time 1 (17.6 ± 5.10 weeks) 2.55 2.0 1.93  
    Time 2 (30.7 ± 2.6 weeks) 2.30 2.0 1.79  
Support score total    0.051 
    Time 1 (17.6 ± 5.10 weeks) 2.72 3.0 1.17  
    Time 2 (30.7 ± 2.6 weeks) 2.64 3.0 1.16  
EPDS anxiety subscale score total    <0.001 
    Time 1 (17.6 ± 5.10 weeks) 3.37 3.0 2.06  
    Time 2 (30.7 ± 2.6 weeks) 2.97 3.0 1.92  
EPDS score total    0.002 
    Time 1 (17.6 ± 5.10 weeks) 6.82 6.0 4.57  
    Time 2 (30.7 ± 2.6 weeks) 6.23 5.0 4.27  
 
 
Table 5.5 describes the behavioural determinants of health. Approximately 79% of 
women intended to become pregnant. Sixty-seven percent of the women reported to have 
never smoked and about 21% reported that they had quit either before or during the 
pregnancy. The majority of the women reported that they had never used substances 
(81.3%), with 2.7% reporting to be current users and 16% reported that they had quit either 
before or during the pregnancy. The number of women who stated that they presently use 
alcohol was 6.5%. However, in the original study women were able to mark more than one 
category as a response in order to try to distinguish the woman who might occasionally 
drink but also have binge episodes that would potentially contribute to problems for the fetus 
(e.g., Fetal Alcohol disorder). Therefore, some women who reported that they were drinking 
a certain amount but also that they had quit were categorized as having quit using alcohol in 
the original study. 
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Table 5.5. Behavioural Characteristics 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n % n % 
Pregnancy Planning     
    No 125 22.7 108 21.2 
    Yes 426 77.3 453 78.8 
Smoking     
    Never smoked 369 67.0 465 81 
    Quit before or during pregnancy 115 20.9 50 8.5 
    Current smoker 67 12.2 60 10.5 
Alcohol Use     
    Never drank alcohol 172 31.2 446 77.7 
    Quit before or during pregnancy 343 62.3 93 16.0 
    Current drinker 36 6.5 36 6.3 
Substance Use     
    Never took drugs 447 81.3 470 81.9 
    Quit before or during pregnancy 88 16.0 89 15.7 
    Current illicit drug use 15 2.7 15 2.4 
 
Table 5.6 describes the frequency of antiemetic and psychotropic medications used 
by women in this sample. Approximately 14% of women at Time 1 and 5% of women at 
Time 2 were taking medication to relieve nausea. Few women were using medications to 
relieve anxiety or depression symptoms, with about 4% and 3% reported for each time 
period respectively.  
 
Table 5.6. Antiemetic and Psychotropic Medications  
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n % n % 
Antiemetic Medication 76 13.8 29 4.9 
Psychotropic Medication 23 4.1 19 3.3 
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5.2 Prevalence of Nausea and Vomiting in Pregnancy  
 Table 5.7 describes the prevalence of nausea and vomiting at both time periods. 
Over 63% of pregnant women experienced nausea and vomiting at Time 1. More than 45% 
of pregnant women experienced nausea and vomiting at Time 2. Of those women who 
experienced NVP at Time 1 (n=320), 181 pregnant women (56.6%) continued to have 
nausea and vomiting in later pregnancy. 
 
Table 5.7 Prevalence of NVP 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n % n % 
No NVP (score of 0) 202 36.7 314 54.6 
NVP Symptoms (score > 0) 349 63.3 261 45.4 
 
Figure 5.2 depicts a histogram of the NVPI score for Time 1 and reports the mean, 
median, and mode scores. Similarly, Figure 5.3 illustrates the NVPI score histogram for 
Time 2. 
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Figure 5.2. NVPI Score at Time 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mean= 2.3 ± 2.97 
Median= 1.0 
Mode= 0.0 
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Figure 5.3. NVPI Score at Time 2 
 
 
 The distribution of the NVPI score at both time periods was severely negatively 
skewed. Therefore, to better understand the determinants of women with more severe NVP 
symptoms, scores of 0 were separated from the NVPI score while remaining scores were 
divided into three equal groups. Scores of 0 were then added to group 1 to form the 
category ʻnone/mild NVPʼ. Moderate NVP was then defined as group two, and severe NVP 
defined as group three. From Table 5.8 we can see that the prevalence of moderate nausea 
and vomiting symptoms, in the last seven days, in this sample of 551pregnant women at 
Time 1 was 24%, and 8.2% in the sample of 575 pregnant women at Time 2. Severe 
nausea and vomiting were reported by 18.9% of women at Time 1, and 14.3% of women at 
Mean= 1.17 ± 2.07 
Median= 0.0 
Mode= 0.0 
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Time 2. Of those women with moderate and severe NVP at Time 1, 13.8% go on to have 
moderate NVP and 21.7% go on to have severe NVP symptoms in later pregnancy. 
  
Table 5.8. Frequency of Reported None/Mild, Moderate and Severe NVP 
 Time 1 (n=551) Time 2 (n=575) 
 (17.6 ± 5.10 weeks)      (30.7 ± 2.6 weeks) 
 n % n % 
None/Mild NVP (Tertile 1 and 0 scores) 315 57.2 446 77.6 
Moderate NVP (Tertile 2) 132 24.0 47 8.2 
Severe NVP (Tertile 3) 104 18.9 82 14.3 
 
Table 5.9 describes the nausea, retching and vomiting data, collected in the 
preceding seven days, for Time 1 and Time 2. The range for scale indices during each time 
period ranged from 0 to 5 and the modal response for each index was 0 for both periods. 
The highest index was nausea, with a mean score at Time 1 of 1.28 ± 1.47. For Time 1, it is 
notable that approximately 78% of women did not vomit and about 67% had no retching; yet 
30.6% experienced nausea 3 to 6 days during the week or more. At Time 2, almost 89% of 
women did not vomit and 80% had no retching, but 12.9% of women experienced nausea 3 
to 6 days during the week or more. When comparing the same women at Time 1 to Time 2 
(n=511), a significant reduction was noted in the severity of reported nausea (Z= -9.54, p< 
0.001), retching (Z= -5.82, p< 0.001), and vomiting (Z = -4.99, p< 0.001), as well as the total 
NVPI score (Z= -9.01, p< 0.001), with a significant reduction in median NVPI levels (Md=1.0 
to 0.0) reported. 
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Table 5.9. Womenʼs Responses to the NVPI at Time 1 (n=551) and Time 2 (n=575) 
  Not at all 
Occasional
ly 
3-6 
days 
/wk Daily 
> 
Once 
/day 
All the 
time 
 
 
Mean ± SD 
 n(%) n(%) n(%) n(%) n(%) n(%)  
Time 1  
Nausea 219 (39.7) 164 (29.8) 51(9.3) 50(9.1) 45(8.2) 22(4.0) 
 
1.28 ± 1.47 
Retching 368 (66.8) 100 (18.1) 26(4.7) 29(5.3) 25(4.5) 3(0.5) 0.64 ± 1.14 
Vomiting 431 (78.2) 67 (12.2) 32(5.8) 9(1.6) 10(1.8) 2(0.4) 0.38 ± 0.86 
        
Time 2  
Nausea 342 (59.5) 159 (27.7) 36(6.3) 20(3.5) 12(2.1) 6(1.0) 0.64 ± 1.01 
Retching 460 (80.0) 67 (11.7) 24(4.2) 14(2.4) 9(1.6) 1(0.2) 0.34 ± 0.82 
Vomiting 511 (88.9) 37 (6.4) 20(3.5) 2(0.3) 4(0.7) 1(0.2) 0.18 ± 0.59 
 
 
Table 5.10 describes the rate of antiemetic medication used by pregnant women 
among severity groups for each time period. Severe NVP was significantly associated with 
the decision to use antiemetic medication both at Time 1 and in later pregnancy.  
 
 
Table 5.10. Comparison of NVP Severity and Antiemetic Medication Use 
  n % χ² p-value 
Time 1 
None/Mild NVP  
(Tertile 1 and 0 scores)     12 
 
15.8 
 
 
(17.6 ± 5.10 weeks) 
Moderate NVP   
(Tertile 2)    25 
 
32.9 
 
 
(n=76) 
Severe NVP  
(Tertile 3)          39 
 
51.3 
 
78.50 < 0.001 
      
Time 2 
None/Mild NVP  
(Tertile 1 and 0 scores)    6 
 
20.7 
 
 
(30.7 ± 2.6 weeks) 
Moderate NVP  
(Tertile 2)      1 
 
3.4 
 
 
(n=29) 
Severe NVP  
(Tertile 3)          22 
 
75.9 
 
95.73 < 0.001 
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5.3 Determinants of Moderate and Severe NVP at Time 1 
The sociodemographic determinants of age, ethnicity, employment, and income 
(p<0.25) were entered into the logistic regression model. The final model, Table 5.11, shows 
that pregnant women who are not working were twice as likely to have moderate NVP 
symptoms, and about 1.8 times more likely to have severe NVP compared to none or mild 
NVP. 
 
Table 5.11. Final Model of Sociodemographic Determinants of Moderate and Severe NVP 
at Time 1 (17.6 ± 5.10 weeks) (n=551) 
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval p-value 
Moderate NVP (Tertile 2)    
     Employment Working    
         No 2.01 1.23, 3.30 0.006 
Severe NVP (Tertile 3)    
     Employment Working    
         No 1.79 1.03, 3.09 <0.001 
 
All obstetrical/biological variables p ≤ 0.25 were entered into the model using 
Backward Stepwise Logistic Regression. This included: gestation, number of pregnancies, 
and number of live-born children. In the final model for the biological/obstetrical 
determinants (Table 5.12), time in weeks was protective in this sample as women were less 
likely to have both moderate and severe NVP compared to none or mild symptoms for every 
additional week in their pregnancy.  
 
Table 5.12. Final Model of Obstetrical/Biological Determinants of Moderate and Severe 
NVP at Time 1 (17.6 ± 5.10 weeks) (n=551)  
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Moderate NVP (Tertile 2)    
    Gestation 0.89 0.85, 0.93 <0.001 
Severe NVP (Tertile 3)    
    Gestation 0.85 0.85, 0.93 <0.001 
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The variables that measure the psychological determinants p ≤ 0.25 were entered 
into the model for logistic regression using backward stepwise regression. Stressors, worry, 
support, moods up and down, history of depression, anxiety, and depression were entered 
in the model. There were no interactions between the terms and no confounding between 
variables in the final model. As the final model for the psychological determinants shows, 
Table 5.13, women who had high levels of worry about their health were almost 1.9 times as 
likely to have moderate NVP. Both groups of women with medium and high worry about 
their health were over 2 times and 3 times more likely to have severe NVP. Also, women 
with symptoms of major depression were 2.18 times as likely to have severe NVP 
symptoms compared to none and mild symptoms. 
 
Table 5.13. Final Model of Psychological Determinants of Moderate and Severe NVP at 
Time 1 (17.6 ± 5.10 weeks) (n=551) 
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval p-value 
Moderate NVP (Tertile 2)    
     Worry own health    
         Low 1.00   
         Medium 1.87 0.77, 2.25 0.401 
         High 1.28 1.17, 2.98 0.009 
Severe NVP (Tertile 3)    
     Worry own health    
         Low 1.00   
         Medium 2.04 1.11, 3.70 0.021 
         High 3.30 1.79, 6.10 <0.001 
     Major Depression (EPDS≥13)    
         Yes 2.18 1.13, 4.20 0.020 
 
 
To derive a model of behavioural determinants, the variables smoking and substance 
use had p-values less than or equal to 0.25 and as such were entered into the analysis. 
Employing a 0.05 criterion of statistical significance, no behavioural determinants were 
significant in the final model.  
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5.4. Final Model for Determinants of Moderate and Severe NVP at Time 1 
 All determinants that had a reported p-value ≤ 0.10 at Time 1 were included in the 
final model to predict the probability that a pregnant women would have moderate or severe 
NVP symptoms compared to mild or less than mild NVP, adjusting for confounding factors. 
The model as a whole explained between 22.2% (Cox and Snell R squared) and 26.2% 
(Nagelkerke R squared) of variance, and correctly classified 62.0% of cases. The Hosmer-
Lemeshow (H-L) test yielded a χ2 (364) of 493.85 and was not significant (p > 0.05), 
suggesting that the model was fit to the data well.  
The final logistic regression model at Time 1, as depicted in Table 5.14, shows 
pregnant women taking antiemetic medication were more than 6.2 times as likely to report 
moderate symptoms and 12.5 times more likely to report severe NVP. Women who were not 
working reported both moderate and severe symptoms almost twice as often. Women who 
reported high levels of worry about their health were 1.5 times as likely to have moderate 
NVP and over twice as likely to report severe symptoms. Pregnant women with symptoms 
of major depression were 2.4 times more likely to report moderate NVP and 2.5 times more 
likely to report severe NVP, compared to mild or less than mild symptoms. In this sample, 
time in weeks was protective as women were less likely to have both moderate and severe 
NVP for each additional week in pregnancy. 
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Table 5.14. Final Model for Determinants of Moderate and Severe NVP at Time 1 (17.6 ± 
5.10 weeks) (n=551) 
None/Mild NVP vs.  
(Tertile 1 and 0 scores) 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Moderate NVP (Tertile 2)    
     Gestation 0.88 0.84, 0.92 <0.001 
     Antiemetic Medication    
         Yes 6.21 2.90, 13.33 <0.001 
     Worry own health    
         Low 1.00   
         High 1.45 1.18, 3.42 0.009 
     Employment Working    
         No 2.14 1.27, 3,62 0.005 
     Major Depression (EPDS≥13)    
         Yes 2.36 1.53, 5.43 0.043 
    
Severe NVP (Tertile 3)    
     Gestation 0.84 0.79, 0.90 <0.001 
     Antiemetic Medication    
         Yes 12.50 9.68, 27.78 <0.001 
     Major Depression (EPDS≥13)    
         Yes 2.54 1.76, 5.15 0.009 
     Worry own health    
         Low 1.00   
         High 2.17 1.19, 3.95 0.012 
     Employment Working    
         No 2.11 1.11, 4.04 0.023 
 
 
5.5 Determinants of Moderate and Severe NVP at Time 2 
The sociodemographic determinants of age, ethnicity, employment, and income (p ≤ 
0.25) were entered into the logistic regression model. Employing a p value of 0.05, no 
behavioural determinants were significant in the final model. 
All obstetrical/biological variables p ≤ 0.25 were entered into the model using 
Backward Stepwise Logistic Regression. This included: gestation, number of pregnancies, 
and number of live-born children as well as moderate and severe NVP symptoms during 
Time 1 for the purposes of exploring the possible intercorrelation between NVP at Time 1 
and Time 2. In the final model for the biological/obstetrical determinants (Table 5.15), 
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pregnant women who experienced moderate NVP at Time 1 were 3.2 and 5.5 times as 
likely to report moderate and severe NVP symptoms. Pregnant women who experienced 
severe NVP at Time 1 were 2.9 and 7.2 times as likely to report moderate and severe NVP 
symptoms.  
 
Table 5.15. Final Model of Obstetrical/Biological Determinants of Moderate and Severe 
NVP at Time 2 (30.7 ± 2.6 weeks) (n=575)  
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Moderate NVP (Tertile 2)    
    Moderate NVP at Time 1    
        Yes 3.21 1.56, 6.62 0.002 
    Severe NVP at Time 1    
        Yes 2.92 1.33, 6.41 0.008 
Severe NVP (Tertile 3)    
    Moderate NVP at Time 1    
        Yes 5.49 2.59, 11.63 <0.001 
    Severe NVP at Time 1    
        Yes 7.19 3.47, 14.93 <0.001 
 
The variables that measure the psychological determinants p ≤ 0.25 were entered 
into the model for logistic regression using backward stepwise regression. Stressors, worry, 
support, history of depression and depression were entered in the model. There were no 
interactions between the terms and no confounding between variables in the final model. As 
the final model for the psychological determinants shows, Table 5.16, women who had high 
worry about their health were 2.5 times more likely to have moderate NVP and 3.4 times 
more likely to have severe NVP, compared to none and mild symptoms. Women with 
symptoms of major depression were 3.3 times more likely to have severe NVP symptoms. 
The presence of high support was protective for severe NVP symptoms in this sample. 
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Table 5.16. Final Model of Psychosocial Determinants of Moderate and Severe NVP at 
Time 2 (30.7 ± 2.6 weeks) (n=575) 
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Moderate NVP (Tertile 2)    
    Worry own health    
         Low 1.00   
         High 2.45 1.22, 4.93 0.011 
Severe NVP (Tertile 3)    
     Worry own health    
         Low 1.00   
         High 3.37 1.86, 6.09 <0.001 
     Support    
         Low 1.00   
         High 0.31 0.17, 0.56 <0.001 
     Major Depression (EPDS≥13)    
         Yes 3.34 1.34, 8.40 0.010 
 
To derive a model of behavioural determinants, the variables smoking, substance 
use, and pregnancy planning had p-values ≤ 0.25 and as such were entered into the 
analysis. Table 5.17 shows the final model from the analysis at Time 2. The behaviour of 
currently smoking was protective for severe nausea and vomiting symptoms in this sample 
of pregnant women. No behavioural determinants were significantly associated with 
moderate NVP. 
 
Table 5.17. Final Model of Behavioural Determinants of Severe NVP at Time 2 (30.7 ± 2.6 
weeks) (n=575) 
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Severe NVP (Tertile 3)    
    Smoking    
         Yes 0.44 0.23, 0.86 0.016 
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5.6. Final Model for Determinants of Moderate and Severe NVP at Time 2 
All determinants that had a reported p-value ≤ 0.10 at Time 2 were included in the final 
model to predict the probability that a pregnant women would have moderate or severe NVP 
symptoms compared to mild or less than mild NVP, adjusting for confounding factors. The 
model as a whole explained between 28.0% (Cox and Snell R squared) and 42.3% 
(Nagelkerke R squared) of variance, and correctly classified 82.0% of cases. The Hosmer-
Lemeshow (H-L) test yielded a χ2 (242) of 267.57 and was not significant (p > 0.05), 
suggesting that the model was fit to the data well.   
The final logistic regression model at Time 2, as depicted in Table 5.18, shows that 
pregnant women in this sample with severe NVP at Time 1 were over 3 times more likely to 
report moderate NVP and about 5.5 times more likely to report severe NVP symptoms. 
Women who reported high levels of worry about their health were 2.3 times more likely to 
report moderate NVP and 3.4 times more likely to report severe NVP, compared to mild or 
less than mild symptoms. Taking antiemetic medication was not protective enough in this 
sample as these women were 26 times more likely to severe NVP compared to mild or less 
than mild symptoms. Women who reported symptoms of major depression were almost 4.1 
times more likely to also report symptoms of severe NVP. Both smoking and high support in 
pregnancy were protective for severe nausea and vomiting in this sample.  
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Table 5.18. Final Model for Determinants of Moderate and Severe NVP at Time 2 (30.7 ± 
2.6 weeks) (n=575) 
None/Mild NVP  
(Tertile 1 and 0 scores) vs. 
Adjusted 
Odds Ratio 
95% Confidence 
Interval  p-value 
Moderate NVP (Tertile 2)    
     Severe NVP at Time 1    
        Yes 3.22 1.31, 7.87 0.011 
     Worry own health    
         Low 1.00   
         High 2.26 1.14, 4.59 0.024 
Severe NVP (Tertile 3)    
    Antiemetic Medication    
        Yes 26.32 7.04, 47.62 <0.001 
    Severe NVP at Time 1    
        Yes 5.52 2.54, 12.05 <0.001 
    Worry own health    
         Low 1.00   
         High 3.40 2.74, 6.62 <0.001 
     Support    
         Low 1.00   
         High 0.32 0.17, 0.62 0.002 
    Smoking    
         Yes 0.34 0.22, 0.92 0.005 
    Major Depression (EPDS≥13)    
         Yes 4.07 1.43, 11.43 0.010 
 
5.7 Nature of the Relationship between NVP and Psychological Determinants 
The association between antiemetic medication use and symptoms of major 
depression (EPDS≥13) is presented in Table 5.19. No statistically significant differences 
were found between antiemetic medication use and major depression at either time point 
(p=0.105, 0.159). However, of women taking antiemetic medication during pregnancy about 
84-85% did not have symptoms of major depression at either time period.  
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Table 5.19. Comparison of Antiemetic Medication Use and Symptoms of Major Depression 
Major Depression (EPDS≥13) n %  χ² p-value 
Time 1 (17.6 ± 5.10 weeks)     
         No 56 83.6   
         Yes 11 16.4 2.63 0.105 
Time 2 (30.7 ± 2.6 weeks)     
         No 17 85.0   
         Yes 3 15.0 1.98 0.159 
 
The association between psychotropic medication use and NVP severity is presented 
in Table 5.20. No statistically significant differences (p=0.13) was found between NVP 
severity at time 1 and women who were administered medication for anxiety or depression 
in pregnancy. Psychotropic medications used in pregnancy were significantly associated 
with severe nausea and vomiting in later pregnancy (p=<0.001). 
 
Table 5.20. Comparison of Psychotropic Medication Use and NVP Severity  
  n %  χ² p-value 
Time 1  None/Mild NVP  11 47.8   
(17.6 ± 5.10 weeks) Moderate NVP  4 17.4   
(n=23) Severe NVP  8 34.8 4.02 0.134 
      
Time 2  None/Mild NVP  7 36.8   
(30.7 ± 2.6 weeks) Moderate NVP  1 5.3   
(n=19) Severe NVP  11 57.9 30.96 < 0.001 
 
 
Women who completed the NVPI at both time periods (n=511) were assessed for 
differences in NVP severity and depression. Fifty-two women (10.2%) had symptoms of 
major depression at time 1. Of these women, 37 (71.2%) ceased to have major depressive 
symptoms in later pregnancy. The severity of NVP among these women (n=37) was 
compared and are presented in Table 5.21. Women with severe NVP were significantly 
associated with symptoms of major depression at Time 1 (p=0.04). No statistically 
significant differences in NVP severity (p=0.91) were noted with women who no longer had 
symptoms of major of depression. However, it is notable that among these women severe 
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NVP decreased from 45.9% at Time 1 to 16.2% at Time 2, and percentages of none or mild 
NVP symptoms increased from 43.2% at Time 1 to 75.7% in later pregnancy.  
 
Table 5.21. Comparison of NVP Severity Among Women with Major Depression (EPDS≥13) 
at Time 1 but not at Time 2 (n=37) 
  n %  χ² p-value 
Time 1 None/Mild NVP  16 43.2   
(17.6 ± 5.10 weeks) Moderate NVP  4 10.8   
 Severe NVP  17 45.9 6.39 0.041 
      
Time 2 None/Mild NVP  28 75.7   
(30.7 ± 2.6 weeks) Moderate NVP  3 8.1   
 Severe NVP  6 16.2 0.18 0.912 
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Chapter 6 
Discussion 
 The discussion of nausea and vomiting in pregnancy and its determinants, as 
outlined in Chapter 3, provides a detailed response to the findings of the study in relation to 
the literature. Implications and future directions based on this research are also proposed.
 This study examined nausea and vomiting in the same group of pregnant women at 
two gestational time points, thus it is one of the few studies using an objective measure to 
explore the condition beyond 20 weeks in pregnancy and during multiple time points (Chou, 
Kuo, & Wang, 2008; Lindseth & Vari, 2005).   
6.1 Prevalence of Nausea and Vomiting in Pregnancy  
In this study women were examined with respect to nausea and vomiting in 
pregnancy at two gestational time points. On average, women at Time 1 were in the second 
trimester of pregnancy (17.6 ± 5.1 weeks) and women at Time 2 were in the third trimester 
of pregnancy (30.7 ± 2.6 weeks). 
At trimester 2, the women in this study showed levels of NVP similar to the rates 
(50%-90%) found in other studies of pregnant women in early pregnancy (Broussard & 
Richter, 1998; Miller, 2002; Woolhouse, 2006). The high prevalence of NVP supports that 
this is a normal physiologic occurrence in early pregnancy. However, in support of previous 
studies that showed approximately 10-32% of pregnant women experiencing late NVP 
(Jewell, 2003; Lindseth & Vari, 2005; Miller, 2002), this study demonstrates an even greater 
amount of women (45%) experience NVP symptoms beyond 20 weeks gestation.  
The sociodemographic characteristics of our study mirror that of an American 
prospective study of 414 predominantly white, upper-middle-class women (Tierson, Olsen, 
& Hook, 1986). Of these women, 55% reported vomiting and 89.4% reported nausea or both 
nausea and vomiting symptoms throughout pregnancy. The results of our study revealed 
that most women did not vomit in the second or third trimesters of pregnancy, although the 
feeling of nausea was more consistent. Comparative analysis is difficult as our study 
examined the condition at two specific one-week intervals, whereas Tierson et al. (1986) 
considered the occurrence of symptoms throughout pregnancy. 
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In this sample, the intensity of NVP symptoms in the second trimester were similar to 
other reports in early pregnancy (Jarnefelt-Samsioe, Samsioe, & Velinder, 1983). Jarnefelt-
Samsioe et al. (1983) reviewed 948 pregnancies among 244 women who all had at least 
three children in Sweden. The authors reported that 91% of women experienced nausea in 
the first trimester, with moderate symptoms reported in 33% of women and severe 
symptoms reported in 17% of women. In our study, 63.3% of women had NVP, with reports 
of moderate and severe symptoms found in 24% and 19% of women, respectively. 
However, comparative analysis of findings is difficult since Jarnfelt-Samsioe and colleagues 
used self-report instead of a scale measure for nausea and vomiting.  
 In our study, levels of nausea and vomiting in the third trimester were significantly 
lower than reports during the second trimester. In contrast to these findings, Chou et al. 
(2008) conducted a prospective and longitudinal study of 91 pregnant women using the 
Index of Nausea, Vomiting, and Retching measure (INVR). They reported the second and 
third trimesters to be associated with significantly lower levels of nausea and vomiting than 
in the first trimester, even though mean INVR scores for the second trimester did not 
significantly differ from the third trimester. However, differences between our findings and 
those of Chou et al. might be explained by the inclusion of both first and second trimester 
women at Time 1 in our sample (n=551). 
6.2 Determinants of Nausea and Vomiting in Pregnancy 
6.2.1 Sociodemographic determinants. In our study, women who were employed 
were more likely to have mild or less than mild NVP compared to women with moderate and 
severe symptoms. Two other studies confirm our finding (Källén, Lundberg, & Åberg, 2003; 
Lacroix et al., 2000); however, the meaning of these correlations cannot be determined 
without knowing how many women took a leave from work or quit work because of the 
nausea and vomiting, or because of decisions related to multiparity. A study of 3675 
Swedish women found a lower rate of nausea and vomiting among pregnant women 
working outside the home (Källén et al., 2003). Similarly, Lacroix et al. (2000) reported that 
NVP was significantly associated with low educational level, low level of income, and part-
time employment. One study found no significant associations between employment status 
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and NVP (Chou et al., 2003). However, differences between our findings and those of Chou 
et al. might be explained by the small sample size of their population (n=113). 
 6.2.2 Obstetrical and biological determinants. NVP severity decreased 
significantly with gestational age among women in the first and second trimester of 
pregnancy (Time 1). This is reasonable since the natural history of NVP is for gradual 
improvement as pregnancy progresses; corresponding with the onset, peak and decline of 
maternal hCG levels. In addition, maternal strategies to cope with NVP may increase over 
time. However, more advanced gestational age was not protective against moderate and 
more severe nausea and vomiting symptoms in the third trimester of pregnancy. 
6.2.3 Psychological determinants. Pregnant women commonly report concerns 
about the health of their baby and the possibility of miscarriage in early pregnancy 
(Georgsson Öhman, Grunewald, & Waldenström, 2003; Statham, Green, & Katesios, 1997). 
Echoing these concerns, our study revealed that pregnant women with moderate and 
severe nausea and vomiting experience high levels of worry regarding their health, at a time 
that should be filled with anticipation and assumption of the mothering role. However, unlike 
women without nausea and vomiting symptoms, these concerns extend beyond the first 
trimester of pregnancy.  
An association between worry and NVP has been reported elsewhere in the 
literature. A retrospective study of 3201 Canadian and American women reported that 
pregnant women with both mild and severe nausea and vomiting perceived their symptoms 
could adversely affect their baby (Mazzotta, Stewart, Atanackovic, Koren, & Magee, 2000), 
although a scale measure of NVP was not used in this study. Canadian women (72%) were 
more often concerned about the consequences of nausea and vomiting to their unborn child 
than the potential risks of drug therapy for treatment than American women (24.7%). High 
levels of worry in pregnancy are a concern considering that the negative impact of 
perceived stress in pregnancy on maternal and fetal outcomes is well documented (Austin, 
2005; OʼKeane & Scott, 2005; Teixeira, 1999). 
A new finding of our study is that pregnant women with more sources of social 
support are less likely to experience severe nausea and vomiting in the third trimester of 
pregnancy. Chou et al. (2003) reported a negative relationship between social support and 
60 
NVP using Part II of the Personal Resources Questionnaire (Weinert, 1987) to measure 
perceived social support among 113 women between 6 to 10 weeks gestation. A lack of 
social support has also been reported among women with the most severe form of NVP, 
hyperemesis gravidarum (Katon, Ries, Bokan, & Kleinman, 1980). Research has also 
revealed that prenatal social support is negatively associated with stress (Chou, Avant, Kuo, 
& Fetzer, 2008) and other studies have positively associated stress with NVP (Kuo, Wang, 
Tseng, Jian, & Chou, 2007; OʼBrien, Evans, & White-McDonald, 2002). Therefore, our 
finding that the support in pregnancy may reduce the risk of more severe NVP in the third 
trimester is consistent with the literature related to stress and support in pregnancy. 
The findings of depression and nausea and vomiting in pregnancy in this study 
confirm the coexistence of these disorders reported by others (Anderson et al., 2004; Chou, 
2003; Kitamura et al., 1996; Mazzotta et al., 2000; Swallow et al., 2004). However, like 
others, our findings do not reveal the causal relationship between NVP and depression in 
pregnancy.  
6.2.4 Behavioural determinants. Our findings support the hypothesis that smokers 
in pregnancy experience less nausea than nonsmokers do (Jarnfelt-Samsioe et al., 1983; 
OʼBrien & Zhou, 1995; Weigel, 1988). In our study, smokers (10.5%) were less likely to 
have severe NVP in the third trimester than non-smokers, a rate that is 4.5% less than 
estimates of smoking among this population (Statistics Canada, 2006). Two theories may 
explain the protective effect of maternal smoking on NVP. First of all, mothers who smoke 
cigarettes have lower levels of circulating maternal estrogen (Weigel & Weigel, 1988) and 
thus may have a decreased risk in having more severe nausea and vomiting, although 
evidence at this point implicating estrogen as a cause for NVP is mostly circumstantial. 
Secondly, both senses of odour (OʼBrien, Relyea, & Lidstone 1997; Swallow, Lindow, 
Masson, & Hay 2005) and taste (OʼBrien & Naber, 1992) have been associated with NVP, 
and the effects of maternal smoking may blunt these senses.  
6.2.5 Antiemetic medication in pregnancy. The hypotheses that women who used 
medication to relieve nausea would report less severe NVP at both time periods were 
rejected.  In this study, the use of antiemetic medications to ease NVP at both time periods 
was associated with more severe nausea and vomiting compared to women who did not 
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use antiemetic medications. It may be postulated that the decision to use antiemetic 
medications to alleviate symptoms may be a consequence of more severe nausea and 
vomiting. Mazzotta et al. (2000) reported the severity of NVP to be the factor most closely 
related to womenʼs decisions to take antiemetic medication. In that study, other significant 
and independently related factors related to womenʼs decisions to take antiemetic 
medication included an adverse effect of NVP on their partnerʼs daily life and feelings of 
depression due to NVP. In this study, we do not know the reasons behind the womanʼs 
decision to use antiemetic medication.  
6.3 Nature of the Relationship between NVP and Psychological Determinants 
Women in our study reported a significant decrease in the degree of nausea and 
vomiting, stress, anxiety and depression significantly between the second and third 
trimesters of pregnancy. This trend would seem to coincide with normal patterns of 
circulating pregnancy hormones. Surprisingly, the use of antiemetic medication in 
pregnancy (14% at Time 1 and less than 5% at Time 2) was significantly associated with the 
occurrence of more severe nausea and vomiting symptoms in the second and third 
trimester of pregnancy. Therefore, the finding that antiemetic use did not reduce symptoms 
of major depression in pregnancy seems logical since these women still suffered severe 
NVP. Only a small percentage of women reported psychotropic medication use, but there 
was a significant association between these women and severe nausea and vomiting in the 
third trimester of pregnancy. This finding may confirm the theory that psychological 
responses to physiological stimuli may interact to exacerbate existing symptoms of anxiety 
and depression (Buckwalter & Simpson, 2002).  
On the other hand, symptoms of major depression may be the direct result of nausea 
and vomiting in pregnancy. One study reported disturbances in the areas of depression, 
anxiety, psychotism, and obsessive-compulsive characteristics in pregnant women with 
hyperemesis gravidarum but no significant differences in the same women when tested 
after they gave birth (Simpson et al. 2001). In our study, of those women who reported 
symptoms of major depression at Time 1 but not at Time 2 (n=37), women with severe NVP 
(n=17) were significantly associated with symptoms of major depression during Time 1. 
However, no significant differences were found in NVP severity at Time 2, although the 
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number of women with severe NVP decreased to 9 cases. While we are unable to ascertain 
the nature of the relationship between NVP and symptoms of major depression, a review of 
the impact of NVP (section 2.2) certainly reinforces the idea that nausea and vomiting could 
subject any normal expectant mother to stress sufficient to trigger adjustment disorders, 
generalized anxiety or even depressive episodes (Bogen, 1994).  
Figure 6.1 summarizes the determinants of moderate and severe and vomiting in 
pregnancy in this sample at Time 1. Likewise, Figure 6.2 summarizes the determinants of 
moderate and severe symptoms at Time 2. The determinants of NVP proposed in the study 
but were not significantly associated are in plain font. The determinants that were found to 
be significant in the bivariate analysis are in italics. Finally, those determinants that were 
significant in the final model are presented in bold font.  
It appears from the final regression model at Time 1 that more severe nausea and 
vomiting in this sample of pregnant women was related to a combination of 
sociodemographic, obstetrical/biological, and psychological factors rather than to the other 
determinants analyzed in this study. The final regression model at Time 2 clearly indicates 
that psychological determinants are associated with more severe nausea and vomiting in 
the third trimester of pregnancy. 
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Figure 6.1 The Population Health Approach Illustrating the Interrelated Determinants of 
NVP at Time 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend:  Bold font = Significant in final model 
Italic font = Significant bivariate analysis 
Normal font = No statistically significant association
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Figure 6.2 The Population Health Approach Illustrating the Interrelated Determinants of 
NVP at Time 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: Bold font = Significant in final model 
Italic font = Significant bivariate analysis  
Normal font = No statistically significant association 
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6.4 Implications for Care Providers 
Nausea and vomiting prior to 20 weeks gestation are common symptoms known by 
health care providers, pregnant women and their families, and the general public; however, 
NVP in later pregnancy is a lesser known phenomenon. Since the etiology remains 
unknown, assessment of the condition focuses on severity, and management is largely 
supportive. Because of the higher than previously reported prevalence of nausea and 
vomiting in the third trimester recorded in this study, health care providers should be aware 
of determinants of women experiencing symptoms both prior to and beyond 20 weeks in 
pregnancy so that a more holistic approach is used to manage symptoms.  
Being aware of women at risk may be important in developing helpful strategies to 
deal with womenʼs suffering and promote the quality of womenʼs lives. In this study, women 
in both the second and third trimester experienced high levels of worry and support reduced 
the severity of nausea and vomiting in later pregnancy. While women may feel that NVP is a 
sign of early pregnancy and is transitory, women experiencing symptoms into the second 
and third trimesters may have a sense that their symptoms are not considered normal in 
pregnancy (Lindseth & Vari, 2005). Women experiencing NVP beyond 20 weeks gestation 
should be informed that 20% to 45% of pregnant women do have late NVP. The media 
portrays NVP as a common occurrence to be endured (Deuchar, 1995), thus validation of 
symptoms beyond the first trimester may assert in women that their suffering is not normal 
and they can and should seek assistance and support from care providers. Since women 
require ʻpermissionʼ to rest and avoid excessive sensory stimulation (OʼBrien & Naber, 
1992), education should be directed at partners and family of the suffering women regarding 
dietary and lifestyle recommendations (e.g., help with cooking, take over household duties, 
and encourage the mother to rest often). Support, understanding, and information regarding 
symptoms and measures for relief may relieve their worry of having continued nausea and 
vomiting during pregnancy.  
Despite the protective effects of smoking cigarettes found in this study, health care 
providers should continue to encourage and support smoking cessation among pregnant 
women. This poses a challenge, as withdrawal symptoms associated with addiction would 
increase the level of stressors facing the pregnant woman. Nonetheless, cigarette smoking  
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is a known reproductive toxin that affects fetal birth weight, incidence of pre-term births, and 
poor future health of children (Statistics Canada, 2006). In addition, the risk of miscarriage is 
increased among smokers compared to nonsmokers (Barkai, Reichman, & Reis, 1994) and 
increasing number of prior miscarriages has been linked nausea and vomiting in pregnancy 
(Louik, Hernandez-Diaz, Werler, & Mitchell, 2006).  
Antiemetic medication was not significantly associated with a reduction in the degree 
of nausea and vomiting in pregnancy. The meaning of this result is unclear; however, it is 
possible that concerns over adverse fetal affects resulted in the women not taking the 
medication as prescribed. In addition to the distress caused by NVP, the ingestion of 
antiemetic medications may cause distress and fears over the effects of such medications 
on the unborn baby (Mazzotta, Stewart, Atanackovic, Koren, & Magee, 2000). Women with 
more severe symptoms need to be reassured of the safety and efficacy of antiemetic 
medications prescribed in pregnancy. It is also possible that the prescribed dosage or the 
timing of medication administration was not sufficient to bring relief to women suffering more 
severe NVP.   
The present study found a significant association between symptoms of major 
depression and nausea and vomiting in the second and third trimester of pregnancy. Acute 
major depressive episodes in pregnancy are often not treated or undertreated (Flynn et al., 
2006; Marcus & Flynn, 1997). Untreated mood disorders in pregnancy increase the risk for 
preterm delivery, poor nutrition, inadequate weight gain, poor prenatal care, inability to care 
for oneself, substance use, consideration of pregnancy termination, and postpartum 
depression (Wisner et al., 2009; Wilsner et al., 2000). Therefore, women with NVP 
represent both a physical and psychological crisis that can be detrimental to both the 
mother and the baby, and pregnant women should be screened and treated for nausea and 
vomiting as well as their depression. Combined efforts may minimize the physical and 
psychological suffering of pregnant women, as well as the potential negative consequences 
of untreated maternal depression on infant development and family functioning (Wisner et 
al., 2009). Furthermore, depression in pregnancy may increase in severity if left untreated 
and can increase risk for future depressions. Treatment strategies that address only the 
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physical symptom of vomiting but disregard the subjective and pervasive nature of nausea, 
the need for support and associated depression are not likely to be as effective. 
6.5 Future research 
Additional research is needed to determine causation of nausea and vomiting in both 
early and late pregnancy, the temporal relation between psychosocial determinants and 
NVP, and then to test interventions addressing pregnant women with more severe nausea 
and vomiting symptoms and depression during different trimesters in pregnancy.  
While our study adds to the literature about the psychosocial factors of NVP we 
particularly need to know more about all the health determinants associated with varying 
levels of nausea and vomiting in pregnancy. In addition, the finding that more severe NVP 
was highly associated with antiemetic therapy needs to be explored, as well as the doses of 
medications prescribed, timing of medication administration, compliance, and other 
treatment modalities used.  
Finally, in cases with severe and extended duration of symptoms, the burden of more 
severe NVP on the developing fetus and long-term consequences to both the mother and 
child warrant further investigation. In addition, the long-term maternal and fetal effects of 
having both nausea and vomiting and depression in pregnancy needs to be examined. The 
additional knowledge gained will enable health care providers to identity women at risk for 
NVP earlier and to advise women early on about the recourse to the symptoms, particularly 
in later pregnancy, thus helping to improve their quality of life throughout pregnancy and to 
ameliorate the potential deleterious consequences to the fetus, baby, and mother herself. 
6.6 Conclusions 
 Sixty-three percent of women experienced NVP during the second trimester of 
pregnancy, with 24% reporting moderate and 19% reporting more severe symptoms. Forty-
five percent of women experienced NVP in the third trimester of pregnancy, with 8% 
reporting moderate and 14% reporting more severe symptoms. To further understand this 
phenomenon, this study examined the differences between those women with moderate 
and more severe nausea and vomiting symptoms on sociodemographic, 
obstetrical/biological, psychological, and behavioural determinants at two gestational time 
points, during the second and third trimesters.   
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Women experiencing more severe nausea and vomiting in the second trimester of 
pregnancy were not working, were prescribed antiemetic medication, had higher worry 
levels, and symptoms of major depression. Gestation mediated symptom severity in these 
women. Women experiencing more severe NVP during the third trimester were non-
smokers, were prescribed antiemetic medication, had high levels of worry, and had 
symptoms of major depression. Higher levels of social support were protective against 
severe nausea and vomiting in the third trimester of pregnancy. Such findings can provide 
health care providers with information needed to identify women at risk and provide them 
with support to avoid increased psychological distress. Until further understanding of the 
causality of such symptoms is available, health care providers should use a holistic 
approach to maximize the quality of life for women experiencing nausea and vomiting in 
pregnancy. 
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Appendix B 
The Nausea and Vomiting in Pregnancy Instrument (NVPI) (Swallow et al., 2002) 
 
Circle the response that fits closest to your experience during the past 7 days. 
 
1. How often have you felt like being sick (nauseated) in the past week? 
 
All the time More than 
once a day 
Daily 3-6 days 
during the 
week 
Occasionally Not at all 
 
2. How often have you retched/dry heaved (but without actually being sick) in the 
past week? 
 
All the time More than 
once a day 
Daily 3-6 days 
during the 
week 
Occasionally Not at all 
 
3. How of ten have you been physically sick (vomited) during the past week? 
 
All the time More than 
once a day 
Daily 3-6 days 
during the 
week 
 
Occasionally Not at all 
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Appendix C 
The Cambridge Worry Scale (CWS) (Statham et al., 1993) 
 
Please circle a number for each one to show how much of a worry it is to you now, 
from 1 if it is not a worry to 5 if it is something that you are extremely worried about: 
                                                                                        Not a worry                                  Major 
Worry 
Your housing 1 2 3 4 5 
Money problems 1 2 3 4 5 
Problems with the law 1 2 3 4 5 
Your relationship with your partner/husband 1 2 3 4 5 
Your relationship with your family and friends 1 2 3 4 5 
Your own health 1 2 3 4 5 
The health of someone close to you 1 2 3 4 5 
Employment problems 1 2 3 4 5 
The possibility of something being wrong with 
baby 
1 2 3 4 5 
Going to hospital 1 2 3 4 5 
Internal examinations 1 2 3 4 5 
Giving birth 1 2 3 4 5 
Coping with the new baby 1 2 3 4 5 
Giving up work (if applicable) 1 2 3 4 5 
Whether your partner will be with you for the 
birth 
1 2 3 4 5 
Possibility of miscarriage 1 2 3 4 5 
If there is anything else that is worrying you or you would like to say anything more about 
any of the above,  
please use this space to tell us about it: 
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Appendix D 
The Edinburgh Postnatal Depression Scale (EPDS) (Cox et al., 1987)  
Please underline the answer, which comes closest to how you have felt in the past 7 
days, not just how you feel today:     
I have felt happy:  
  Yes, most of the time 
Yes, some of the time 
No, not very often 
No, not at all 
 
In the past 7 days: 
1. I have been able to laugh and see the funny side of things: 
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all 
 
2. I have looked forward with enjoyment to things: 
As much as I ever did 
Rather less than I used to 
Definitely less than I used to  
Hardly at all 
 
3. I have blamed myself unnecessarily when things went wrong: 
Yes, most of the time 
Yes, some of the time 
Not very often 
No, never 
 
4. I have been anxious or worried for no good reason: 
No, not at all 
Hardly ever 
Yes, sometimes 
Yes, very often 
 
5. I have felt scared or panicky for no very good reason: 
Yes, quite a lot 
Yes, sometimes 
No, not much 
No, not at all 
 
6. Things have been getting on top of me: 
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Yes, most of the time I havenʼt been able to cope at all 
Yes, sometimes I havenʼt been coping as well as usual 
No, most of the time I have coped quite well 
No, I have been coping as well as ever 
 
7. I have been so unhappy that I have had difficulty sleeping: 
Yes, most of the time 
Yes, sometimes 
Not very often 
No, not at all 
 
8. I have felt sad or miserable: 
Yes, most of the time 
Yes, quite often 
Not very often 
No, not at all 
 
9. I have been so unhappy that I have been crying: 
Yes, most of the time 
Yes, quite often 
Only occasionally 
No, never 
 
10. The thought of harming myself has occurred to me: 
Yes, quite often 
Sometimes 
Hardly ever 
Never 
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Appendix E 
Summary of Studies of NVP and Psychosocial Determinants of Health 
 
Autho
r 
Site Sam
-ple 
size 
Gesta-
tion 
(weeks
) 
Tool* % NVP Psycho-
metrics 
Sample 
characteris
tics 
Determinants 
of NVP 
Comments 
Chou 
et al. 
(2008) 
Taiwa
n 
91 T1 6-10 
T2 16-
18 
T3 28-
32 
INVR  
(0-32 
range) 
Not 
reported 
 
T1 mean 
8  
T2 mean 
2.5  
T3 mean 
2 
States tool 
valid & 
reliable in 
English 
perinatal 
studies 
Age 30 ± 
4.2 
Employed 
79% Parity-
1 59% 
college level 
43% 
planned 
pregnancies 
59% 
Stress 
Support  
Fatigue 
 
1st & 2nd tri: 
fatigue affected 
by NV, stress 
correlated with 
fatigue & not 
NV, stress 
negatively 
correlated with 
support 
 
 
Longitudinal 
 
NV pattern: 
1st trimester 
had 
significantly 
higher 
levels than 
trimesters 2 
& 3. 
Stress & 
Support 
levels 
remained 
same 
throughout 
trimesters. 
Shih-
Hsien 
et al. 
(2007) 
Taiwa
n 
150 6 -16  
 
Mean 
11.3 
INVR NV 
occurred 
between 
week 3-
15 gest-
ation  
 
3 groups: 
Mild 
Moderat
e 
Severe 
States tool 
valid & 
reliable in 
English 
perinatal 
studies 
Age 28 ± 
4.4 
Employed 
65% Parity-
1  52% 
college level 
51% 
unplanned 
pregnancies 
52% 
Stress 
Support 
Maternal- 
Psychosocial- 
Adaptation 
 
Mild NV: sig 
lower stress 
levels, more 
accepting of 
pregnancy 
Moderate NV: 
less accepting 
of pregnancy 
 
Severe NVP: 
sig. higher 
stress levels, 
less accepting 
of pregnancy, 
feared more 
helplessness & 
loss of control 
in labor than 
mod/mild NV 
groups. 
Support & 
Psychosoci
al 
adaptation 
not different 
among 3 
severity 
groups. 
 
Causal 
relation b/w 
stress, lack 
of 
pregnancy 
acceptance 
& NV not 
determined. 
 
Mild & Mod 
NV had 
better 
adaptive 
responses 
to 
pregnancy 
acceptance 
and labor 
fears. 
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Chou 
et al. 
(2007) 
Taiwa
n 
243 6-16 
week 
INVR 77.4% 
prevalen
ce 
 
Mild 25% 
Mod 
36.2% 
Severe 
12.3 
States tool 
valid & 
reliable in 
English 
perinatal 
studies.  
 
Pilot study 
conducted 
prior to this 
research to 
ensure 
language 
accuracy & 
cultural 
appropriaten
ess. 
Age 28 ± 
4.3 Married 
100% 
Employed 
70% Parity-
1  50% 
college level 
50% 
unplanned 
pregnancies 
50% 
Stress 
Support 
Pregnancy 
Planning 
Psychosocial-
Adaptation 
 
Severe NV 
associated with 
high stress 
may be 
mediated by 
support.  
 
Women at risk 
for poor 
adaptation 
have severe 
NV. 
 
 
… 
Lacas
se et 
al. 
(2008) 
Montre
al, 
Canad
a 
367 ≤ 16 
 
Mean 
11±1.8 
PUQE 
(range 
3-15),  
78.5% 
prevalen
ce in 1st 
trimester 
 
Mean 
Nausea 
intensity 
4.7 ± 2.5  
 
 
States tool 
valid & 
reliable in 
previous 1st 
trimester 
studies. 
Age 31.7 ± 
4.7 Living 
with 
partner/othe
rs 
97.8% 
Employed 
76% Parity-
1 53% 
University 
completed 
62% 
Income>$80
000 43%  
NVP presence 
associated with 
both lower 
physical & 
mental scales. 
 
Intensity of 
nausea 
symptoms, 
more severe 
NVP & 
nonpharmacolo
gical methods 
to ease 
symptoms 
associated with 
poorer 
NVPQOL. 
 
Higher 
gestational age 
& having 
private 
insurance plan 
associated with 
superior 
NVPQOL. 
 
Women with 
more severe 
NVP had 
mental QOL 
scores similar 
to women with 
postpartum 
depression.  
 
Primary 
outcome: 
NVP 
specific 
QOL 
 
 
First 
NVPQOL 
study to 
account for 
confounding 
factors with 
multivariate 
analysis. 
 
Caucasians 
had worse 
QOL than 
Asians & 
Hispanics, 
however 
small 
minority 
groups in 
sample. 
 
Controlled 
for multiple 
psychosoci
al variables. 
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Swallo
w et 
al. 
(2004) 
Northe
rn 
Englan
d 
273 Range 
8-18  
 
Mean 
12.8 ± 
2.8 
NVPI Prevalen
ce not 
reported.  
 
Mean 
NVPI 4.3 
± 3.9 
 
 
These 
authors 
created the 
tool & 
validated it 
for use in 
2002. 
Caucasian 
98%, no 
other 
demographi
c data 
reported 
50.5% found to 
have potential 
psychiatric 
problems.  
NVP 
associated with 
somatic 
symptoms 
(r=0.35), social 
dysfunction 
(r=0.25), 
anxiety/insomni
a (r=0.16) & 
severe 
depression (r-
0.17). 
p=<0.001 for 
all correlates. 
Casual 
relationship 
undetermin
ed. 
 
The internal 
validity of 
the GHQ 
may be 
questionabl
e for 
pregnant 
women. 
 
More NVP = 
more ill-
health 
perception. 
However, 
mood 
perception 
not affected 
by NVP 
severity. 
Mazzo
tta et 
al. 
(2000) 
Canad
a 
320
1 
Retro-
spective 
All 
telepho
ne 
respon-
dents 
had 
reporte
d 
previou
s or 
current 
NVP. 
Not 
applicabl
e 
States tool 
valid & 
reliable in 
previous 1st 
trimester 
studies. 
Age 28.3 ± 
5.0  
Parity-1 
48% 
Planned 
pregnancy 
75% 
Elective 
termination 
3.4% 
 
Most 
pregnancies 
resulted in 
term infants 
with 
average 
birthweight. 
 
 
1st trimester: 
more severe 
symptoms & 
more nausea 
compared to 
vomiting.  
60.5% took 
anti-emetic 
therapy. 
 
More likely to 
have taken 
antiemetic 
therapy if 
vomiting 
severely. 
Severe NV 
associated with 
depression, 
consideration 
of pregnancy 
termination, 
adverse affect 
on relationship 
with partner & 
partnerʼs daily 
life, & fear of 
NVP harming 
the baby. 
 
 
 
 
Interviewee
s may 
report 
severity of 
symptoms 
to be higher 
than 
actuality as 
study 
retrospectiv
e in design.  
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Munch 
et al. 
(2010) 
Califor-
nia, 
U.S.  
93 Mean 
11.9 ± 
3.5 
NVPQ
OL, 
SF36 
PUQU
E 
NVP 
51.6% 
Hyper-
emesis 
gravidar-
um 
31.2% 
 
QOL is 
low for 
HG or 
NVP 
women 
in the 1st 
trimester 
compare
d to 
asympto-
matic 
U.S. 
women 
in 1st 
trimester. 
States 
although 
NVPQOL 
validated, it 
does not 
have 
published 
normative 
values. 
Age 27.6 ± 
6.1 
Partnered 
72% 
<College 
level 61.3% 
Hispanic 
73% 
Multiparous 
52.7% 
 
HG women 3-6 
times more 
likely than NVP 
women to have 
low QOL 
scores. For 
both NVPQOL 
& SF36 tests, 
perceived 
symptoms 
severity & 
marital status, 
depression, 
age seemed to 
be equally or 
more important 
contributor to 
low QOL than 
having HG 
diagnosis. 
 
 
Controlled 
for 
psychosoci
al variables 
& compared 
HG with 
NVP. 
Psychosoci
al 
interactions 
also 
explored. 
 
Having HG 
alone didnʼt 
fully explain 
hypothesis 
of lower 
QOL, the 
presence of 
some NVP 
symptoms 
with 
psychosoci
al factors 
put these 
women 
equally or 
more at 
risk. 
 
 
 
Gerrau
d et al. 
(2008) 
Bavari
a, 
Germa
ny 
422 1st 
trimeste
r 
anti-
emetic 
pre-
scrip-
tion 
(A04) 
Antiem-
etic use 
for NVP 
7.5% 
Not 
applicable 
Median 32, 
Working 
52.3%, 
European 
95.7% 
German 
91.5% 
Partnered 
92.5% 
Parity-1 
36.5% 
Current 
smokers 
4.2% 
NVP risk 2x 
higher for non-
smokers (OR 
2.03, CI 1.02-
4.05) and 
dropped 3% 
/year in age 
(OR 0.97, CI 
0.94-0.99). 
Single 
increased risk 
by 50% (OR 
1.49, CI 1.24-
1.79) & for 
these women 
working 
lowered risk by 
2/3 (OR 0.4, CI 
0.24-0.49). 
Interactions 
among 
correlates 
explored.  
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Bozzo 
et al. 
(2006) 
Toront
o, 
Canad
a 
2 x 
179 
1st 
trimeste
r 
Self-
ident-
ified 
NVP 
Depress-
ed with 
NVP 
61% 
 
Non-
depress-
ed with 
NVP 
68% 
Self-
identified as 
having NVP 
or not. 
Depressed: 
Age 32.5 ± 
4.2  
Gravidity 2 
Parity 1  
Nondeprese
d:  
Age 32.4 ± 
5.8  
Gravidity 2 
Parity 0  
 
Depression, 
Age 
Gravidity, 
Parity 
 
Logistic 
regression did 
not identify any 
correlates as 
significantly 
explaining 
NVP. 
 
No difference 
in NVP 
incidence 
between the 2 
groups. 
Comparison 
between 
depressed 
women Tx 
with 
antidepress
ants & 
nondepress
ed women. 
 
Respondent
s called 
“hotline” to 
partake in 
original 
study. 
Louk 
et al. 
(2006) 
Boston
, U.S. 
224
87 
Duratio
n & 
onset 
recorde
d.  
 
Long 
duration 
group 
(>4mon
ths 
NVP)  
 
Late 
onset 
group 
(after 
1st 
trimeste
r) 
 
 
Self 
identi-
fied 
NVP 
NVP 
66.7%  
Self-
identified as 
having NVP 
or not. 
NVP 
decreased 
with age 
 
NVP 
increased 
with 
increasing: 
gravidity, 
prior 
miscarriage
s. 
 
NVP higher 
in twins 
than 
singletons. 
 
NVP began 
between week 
5-8 & lasted for 
<4months. 
 
Longer 
duration NVP 
more common 
with lower 
income & 
younger age, 
multigravida, 
unplanned 
pregnancy. 
 
No smoking 
effect 
observed. 
No changes 
between 
normal and 
malformed 
infants. 
 
Earlier onset: 
less-well 
educated, 
lower income, 
black ethnicity 
Very large 
sample 
 
Women 
with late 
onset might 
have also 
presented 
late to 1st 
prenatal 
visit.  
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Lacroi
x et al. 
(2000) 
Montre
al, 
Canad
a 
160 14 & 22 
weeks 
McGill 
Naus-
ea 
ques-
tionn-
aire 
Nausea7
4%  
Validated in 
samples for 
cancer 
therapy. 
Nausea 
lasted mean 
34.6 days. 
 
“Morning 
sickness” 
1.8% 
whereas 
80% 
reported 
nausea 
lasting all 
day. 
 
50%  
relieved by 
week 14, 
90% no 
NVP by 22 
weeks 
Results 
indicate that 
nausea 
experienced by 
pregnant 
women is 
similar in 
character & 
intensity to the 
nausea 
experienced by 
caner 
chemotherapy 
clients. 
 
Kuo et 
al. 
(2007) 
Taiwa
n 
150 1st 
trimeste
r 
INVR Mild or 
<Mild, 
Mod, 
Severe 
States 
validated in 
both English 
and Taiwan 
popula-tions. 
 Stress 
Social Support 
Maternal 
Adaptation 
 
Stress different 
among 3 
severity 
groups, 
support & 
adaptation not 
different. 
 
Mild NVP had 
significantly 
lower stress & 
severe NVP 
had 
significantly 
higher stress 
levels. 
 
Severity 
significantly 
associated with 
subscales of 
“acceptance of 
pregnancy” & 
fear of 
helplessness & 
loss of control 
during labor.” 
Cross-
sectional & 
comparative 
design. 
 
